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ABSTRACT
PROTEIN CONTRIBUTIONS OF THE MALE ACCESSORY ORGANS TO THE 
COMPOSITION OF HUMAN SEMINAL PLASMA AS DETERMINED BY 
HIGH RESOLUTION TWO-DIMENSIONAL ELECTROPHORESIS
Edward E. Gaunt 
Old Dominion University 
and
Eastern Virginia Medical School,
December, 1983 
Director: Dr. James H. Yuan
Human Seminal Plasma was evaluated using a High 
Resolution Two-Dimensional Electrophoresis technique adapted 
by this laboratory. Seminal plasma from healthy volunteers 
with recently proven fertility were characterized using this 
technique to establish "normal" protein distribution
patterns in the two-dimensional polyacrylamide gel slab. In
addition, time studies were performed on selected specimens
to determine the effects of liquefaction on seminal plasma 
protein composition within the first several hours after 
collection. Split ejaculates were collected for
identification and elaboration of accessory organ components 
in the whole seminal plasma specimen. A more direct
approach to accessory organ component analysis involved 
electrophoresis of semen from patients with known fertility 
disorders (i.e. reproductive organ dysgenesis or
dysfunction), patients who have undergone surgical
procedures (varicocele repair, vasectomy, trans-urethra 1
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resection etc.), or specimens from patients who have 
produced secretions as a result of prostatic or seminal 
vesicle massage in the course of urological examinations. 
From these results, patterns of protein "spots" in the 
two-dimensional gel were associated with a particular 
accessory organ. Finally, seminal plasma from infertile 
individuals suffering from (idiopathic) polyzoospermia, 
hyperspermia, oligozoospermia, or azoospermia were
evaluated.
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I. INTRODUCTION
GOD created man in his image; in his 
image he created him; male and female he 
created them. God blessed them saying 
"Be fruitful and mu 11 i p i y . . ." Tha t i s
why a man leaves his mother and father
and clings to his wife, and the two of
them become one body.
(Genesis 1:27-28, 2:24)
Child bearing and midwifery in most ancient societies
was a task generally left to women. Over the years however, 
these early practices gradually became formalized as a
branch of medicine known as obstetrics. Women who had 
difficulty in conceiving, or who remained barren in their 
marriages, began consulting these specialized physicians in 
their desire to discover the reason for their "problem". 
Out of this grew the discipline of gynecology - that branch
of medicine dealing with the bodily functions and diseases
peculiar to women. Often, after finding no significant
abnormalities on thorough examination of the woman, and 
ascertaining that her husband was producing "viable" semen
based on rudimentary semen analysis, she was pronounced 
infertile for idiopathic reasons.
Today, in the United States, there are a surprisingly 
large number of couples desiring to "be fruitful and 
multiply", but who have remained childless because of 
fertility problems. It is now known however, that between
1
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30% and 40% of the time it is the husband who is at fault
(women still account for 50% of the problem, with the
remaining portion being undiagnosed or attributed to both 
par tner s ) (1,2).
The diagnosis of decreased male fertility has, until
recently, been performed by a variety of medical specialists 
including gynecologists, urologists, endocrinologists, and 
even psychiatrists. As more and more is learned about the 
complexities of male reproduction, clinicians are becoming
more dependent on a relatively new type of specialist: the
Andrologist, or one who specializes in male fertility
disorders.
A . The Male Reproductive System.
1. Developmental Aspects : The human male reproductive
system consists of both the primary and secondary (or 
accessory) sex organs along with the external genitalia.
Phenotypic development of an XY individual i n u t e r o is
dependent upon proper hormonal stimulus of the bipotential 
gonad. Placental chorionic gonadotrophin (hCC) along with 
maternal lutinizing hormone (LH) cause mesenchymal cells (or 
the interstitial cells of Leydig) in the medullary region of 
the primitive gonad to begin producing testosterone which, 
along with its metabolites (primarily 5-alpha-dehydro-
testosterone) are regionally concentrated by an androgen
binding protein (A BP). This substance is produced by the
adjacent somatic or Sertoli cells under the influence of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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maternal follicle stimulating hormone (FSH). These 
developments normally occur at 6-8 weeks gestation.
Simultaneous with the above events, gonocytes in the 
surrounding germinal epithelium begin proliferation and
differentiation into spermatogonia.
Increased androgen levels cause further masculin-
ization by insuring development of the Wolffian duct into
efferent ductules, the epididymides, vasa deferentia and 
seminal vesicles. Similarly, FSH stimulates production of
an inhibition factor which causes degeneration of the 
Mullerian duct system which would have developed into the 
uterus and oviducts in a genotypic (XX) female.
The development of male ezternal sez organs also is 
influenced by testosterone. The enzyme 5-a-reductase
present in genital skin converts testosterone to
5-a-dihydrotestosterone (DHT) which is responsible for
mid-line fusion of the primoidial urethral folds and 
labio-scrota 1 swellings to form the penis (and associated
urethral glands), the scrotum, and the prostate. Absence or 
deficiency of this enzyme results in defects of genital 
development (3,4).
Leydig cell activity is quiescent during childhood 
development, becoming active again at puberty with the 
development of secondary sezual characteristics and the
onset of the final stages of spermatogenesis resulting in 
fertility. Defects at any stage of male development can 
result in subfertile individuals as can environmental 
factors and/or physical trauma in later life. Other reasons
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
for male subfertility will be discussed in subsequent 
paragraphs.
2. M a 1e Sea Organs and Semen Production : The testes
are located outside of the body cavity in the scrotal sac so 
that countercurrent heat exchange in the internal spermatic 
or cremasteric vein will allow the heat sensitive germinal 
epithelia to experience temperatures that are two to three
degrees (Celsius) lower than the normal body temperature.
This location does leave them more susceptible to mechanical 
injury and environmental radiation - both of which can 
severely hamper sperm production.
Developing spermatozoa are released into the coiled 
seminiferous tubules and conducted to the rete testes by the 
convergent tubuli recti (see Figure 1). Testicular seminal
plasma (5,6) is initially formed in the seminiferous tubules 
and is probably a product of Sertoli cell and Leydig cell 
activity, as well as of the secretory epithelia of tubuli
recti, rete testes, and possibly the efferent ducts.
Testicular plasma is an isoosmotic fluid with the major 
solutes being the electrolytes sodium and chloride. The 
protein concentration is low: less than 20 g/dl in the bull
(7). The major non-serum proteins in testicular plasma are 
thought to be Androgen Binding Protein (ABP) and Transferrin 
(TF > . The Blood-Testes barrier was postulated in rats by 
Setchell et. a l . in 1969 (8), and later observed in humans
by Kosfcimies (9). This barrier is thought to be responsible
for the fluid concentration of serum proteins in and around 
the seminiferous tubules. Conversely, this same barrier
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
FIGURE 1. The Male Reproductive System: a. Ureters;
b. Ampulla; c. Seminal Vesicles; d. Prostate; 
e. Vas Deferens; f. Varicocele; g. Bulbo­
urethral (Cowper's) Gland; h. Caput Epididymis; 
i. Rete Testis; j . Cauda Epididymis; k.
Testicle; 1. Seminiferous Tubules; m. Urethral 
(Li 11re 1s) Glands; n. Urethra; o. Bladder. 
(From Glasser Ell).
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FIGURE 1. The Male Reproductive System.
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prevents testicular components from coming in contact with 
the blood stream causing antibody formation.
Spermatozoa in testicular plasma are immature, 
nonmotile, and incapable of fertilization. Kinoplasmic 
droplets are observed at the junction of the head and neck 
region of these inmature forms. This kinoplasmic droplet 
contains the testes specific LDH-X; a sixth isozyme of 
lactate dehydrogenase not found in serum consisting of a "C4 
homotetramer" as described by Music and Rossmann (5, p. 103).
Upon passing from the ductuli efferentes into the caput 
epididymis, testicular plasma is rapidly concentrated by the 
absorption of fluids from the epididymal lumen. The human 
epididymides are coiled tubes approximetely 5 meters long 
and are generally divided into three regions: the head
(caput), the body (corpus), and the tail (cauda). The
resorptive capacity of the epididymis varies with location, 
but approximately 99% of the fluid leaving the testes is 
absorbed. Sperm maturation also takes place in the
epididymis under the influence of testicular androgens 
produced by the interstitual (or Leydig) cells in the
seminiferous tubules. These androgens are concentrated and 
transported into the caput by ABF. The epididymis itself is 
also dependent on testicular androgen for maintenance of 
structural integrity and physiological function.
Part of the spermatozoal maturation process in the
epididymides includes the deposition of epididymis specific 
glycoproteins on the surface of the sperm cell (10,11). 
Spermatozoal maturation is also highly dependent on the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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androgen controlled levels of sia Iomucoproteins and 
lipoproteins produced by the epididymides, thus explaining 
the high levels of glycosidases and other lysosomal proteins 
found in this region.
Another function of the epididymides is the removal of 
dead, dying, or otherwise defective spermatozoa primarily by 
phagocytic activity, but also by the action of lysosomal 
enzymes such as acid phosphatase, deoxyribonuclease, and 
proteases (12). Normal sperm are protected from these 
activities by their mucoprotein coat and also due to the 
presence of enzyme inhibitors. All of these degratory
activities contribute to the cellular debris observed in 
ejaculated seminal plasma.
As spermatozoa progress through the corpus of the
epididymis to the cauda, they shed their kinoplasmic or
cytoplasmic droplets and become progressively more motile. 
Degeneration of these droplets by phagocytic or lysosomal 
activity results in the release of LDH-X and other 
cytoplasmic contents into the lumen of the epididymis thus 
leading to their possible detection in the ejaculated plasma 
(6, 13, 14) .
Upon leaving the cauda of the epididymides, the semen 
enters the vasa deferentia which serve primarily as
"conduits" from the testes up through the inguinal canal and 
on to the terminal dilitation known as the ampullae (located 
anterior to and slightly lower than the bladder in the 
vicinity of the prostate). The vasa deferentia also have
limited secretory and resorptive capabilities: these
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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activities also being androgen dependent. Very little, if 
any, degratory activities occur in these organs.
During embryonic development, the terminal portion of 
each vas deferens becomes dilated to form the ampullary
glands. At 13 weeks development, a "diverticlum" forms on 
each ampulla which develop into the seminal vesicles (SV)(3, 
15). By the end of the second trimester, vas deferens and 
seminal vesicle structural development is essentially 
complete. By the end of the seventh fetal month, the
seminal vesicles take on their adult form and begin 
secretory activities which continue until the child is
between one and two years old. SV secretions then subside 
until the onset of puberty.
The ampulla serve as the primary storage recepticles for 
spermatozoa prior to ejaculation and not the seminal
vesicles as originally believed. Although both glands may
exhibit secretory activity, the seminal vesicles are the 
primary organs of secretion in the male reproductive tract 
(5 , 16, 17). The bulk of the seminal plasma constituents
produced at ejaculation are secreted by the seminal
vesicles. Major HSP components assimilated by the seminal 
vesicles include fructose, and enzymes associated with semen 
coagulation as well as the prostaglandins (which were 
originally thought to be primarily products of the 
prostate). Secretory activity in the seminal vesicles is 
under strict androgenic control. Any abnormality in
testosterone output seriously affects SV secretion.
Since the seminal vesicles and the vasa
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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d e £erentia/ampul 1ae are of mesonephric duct origin,
congenital disturbances may result in non-development of 
both of these organ systems. Failure to palpate the vasa
deferentia on clinical examination of azoospermatic
individuals may indicate a lack of the seminal vesicles as
well. This can be verified by testing for fructose in the 
ejaculated semen. Since fructose is produced exclusively in
these organs its absence is diagnostica11y significant.
The point at which each seminal vesicle stems from
their respective ampullary gland gives rise to the 
contralateral ejaculatory ducts which converge in the 
prostate and open into the prostatic urethra at the
verumontanum.
The prostate is probably the most well studied of the 
accessory organs because of its propensity for causing 
problems in later life. The prostate is the largest of the
accessory glands, situated behind the pubic symphysis and 
surrounding the urethra as it leaves the base of the
bladder. Embryonical1y , the prostate arises primarily from
endodermal tissue in the urogenital sinus, but includes 
tissue arising from both the Wolffian and Mullerian ducts as 
well (18). Whereas seminal vesicle and other Wolffian duct 
tissue development is under the control of testosterone, 
prostatic endoderm does not begin development until 
testosterone is converted to 5-a-DHT by the emergence of
5-a-reductase activity in the urogenital tract. This
differentiation is usually observed around 11-12 weeks 
ge s ta t iona1 a g e .
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McNeal (19) has described four major subdivisions of 
the adult prostate: 1) the non-glandular stroma, 2) the 
peripheral zone (surrounding the urethra), 3) the central 
zone (between the ejaculatory ducts and the proximal 
urethra), and 4) the pre-prostatic or transitional segment. 
Of these four divisions, the central zone is believed to be 
of Wolffian mesodermal origin and, as such, is least 
affected by the action of the reduced androgen D H T . The 
transitional area, on the other hand, represents a mixture 
of bladder and urogenital sinus germ layers and (like other 
transitional epithelia) is subject to dysplasias (e.g. 
benign prostatic hyperplasia - BPH) in later life as 
androgen/estrogen ratios change.
The peripheral zone is the principal site of prostatic 
carcinoma formation. Prostatic carcinogenesis, once
developed, is androgen-dependent, with the cancer tissues 
taking up considerably more testosterone than the 
surrounding normal tissue (18). Merchant et a l . (20), as 
well as others (21), have shown that the prostatic utricle - 
an estrogen sensitive Mullerian duct vestige - is on very 
rare occasions subject to a form of endometrial carcinoma 
emphasizing the significance of the embryonic origin of the 
various adult structures.
The prostate is an exocrine gland producing both 
apocrine and merocrine type secretions. Apocrine secretions 
occur when the apical portion of the glandular epithelia 
break down and release part of the cellular contents into 
the ductal lumen. This type of secretion is responsible for
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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the relatively high concentration of what are generally 
regarded as intracellular constituents present in the 
emitted seminal plasma.
The bulbo-urethral (or Cowper's) glands are situated in 
the urogenital diaphragm just below the prostate. Excretory 
ducts from these paired glands empty into the bulbous 
urethra. These glands are the male counterpart of the 
female Bartholin's glands (22). Since there are so few 
dysfunctions or other pathological conditions associated 
with these glands, they have not been well studied, and thus 
very little is known about their physiological role in male 
reproduc t i o n .
If little is known about Cowper's glands, even less is 
known about the urethral glands even though they were 
discovered by Alexis Littre in 1700! These numerous glands 
are found throughout the corpus spongiosum and empty into 
the cavernous urethra. Their development is not observed 
until late in the second trimester. The secretions of these 
glands, as well as the bulbo-urethral glands, may serve to 
buffer and lubricate the distal urethra prior to
ejaculation, and in lower animals have been shown to exhibit
pheromonal properties as well (5, p. 9).
3. The Product ion o f Semen : As mentioned earlier,
male fertility is not initiated until the onset of puberty. 
At that time, increased androgen levels signal the testes to 
begin the final stages of spermatogenesis and the accessory 
glands to once again begin secretion of seminal plasma.
As spermatozoa are released from the germinal cells in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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the testes, they are carried to the epididymis by 
androgen-dependent neuromuscular contractions of the ductuli 
efferentes. It is here that they shed their kinoplasmic
droplets and gradually become more motile and capable of
fertilization as they approach the cauda. The testicular
plasma in which these events take place is almost entirely 
reabsorbed by the epididymis leaving a high concentration of 
spermatozoa in an iso-osmotic fluid in which most of the
osmotic force is provided by organic solutes such as
g1ycery1phosphoryIchoIine (as opposed to the normal 
i no r gani c i o n s ) .
Neuromuscular contractions of the cauda espel the
epididymal semen into the vasa deferentia which then 
transport the semen outward by weak contractions of the 
muscularis during periods of sexual inactivity or by strong 
paristaltic actions mediated by hypothalamic hormones and 
the sympathetic nervous system during sesual arousal. 
Spermatozoa are stored in the ampullae prior to ejaculation 
but may be detected in the urine with extended periods of 
cont inence.
Neurological mechanisms controlling ejaculation are 
quite complex. Kedia and Markland (23) have described three 
phases of the process; seminal emission, antegrade 
ejaculation, and projectile ejaculation.
Cortical response to afferent somatic input from the
genitalia (via the pudental nerve) results in an increase in
efferent sympathetic activity from the thoracolumbar spinal 
ganglia and hypogastric nerve. This increased neural output
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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causes smooth muscle contractions in the various accessory 
organs resulting in the secretion of their contents into the 
ductal lumina (seminal emission) followed by ezpression into 
the posterior urethra with partial bladder neck closure 
(antegrade ejaculation). Parasympathetic outflow (pelvic 
nerve) results in clonic striated muscle contractions of the 
various cavernosus muscles, as well as those in the pelvic 
floor and lower body. With complete closure of the bladder
neck, the semen is rapidly propelled outwards in rhythmic
projectile contractions.
Ejaculation is a sequential event with the various 
organs contributing their contents to the ejaculatory stream 
(generally) in a specific order. The urethral glands 
(Cowper's and Littre's) being in the distal portion of the 
urethra, release their mucilaginous secretions during the 
excitatory phase, and may be emitted (in part) as a
pre-ejaculatory secretion prior to orgasm. These scant 
secretions may make up only 3-5% of the total semen volume.
Prostatic secretions constitute the majority of the 
first portion of the ejaculatory stream, comprising 15-20% 
of the total volume. The initial portion of the ejaculate
is also high in spermatozoa along with their attendant
epididymal and ampullary secretions. These constitute 7-10% 
of the total semen volume. The seminal vesicle secretions
are emitted last and make up a majority of the total seminal 
plasma volume - approximately 70-80%.
Numerous researchers (24-31) over the years have made 
use of the "split ejaculate" technique in which semen is
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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collected in several discrete fractions. This technique has 
proven to be useful for evaluating the components of the 
various fractions and their attributed organ systems. First 
fractions/ being rich in spermatozoa , have even been 
successfully used in insemination procedures - especially 
when an individual suffers from o 1igozoospermia as a result 
of hyperspermia (24). Figure 2 shows a typical distribution 
of three semen components in a split ejaculate.
Amelar and Hotchkiss (24) found that in approximately 
6% of the individuals they sampled (5 out of 86) there was 
a reversal in the order in which spermatozoa were released, 
with the terminal portions of the ejaculate being richer in 
sperm than the initial portions. In two cases, pregnancy 
resulted when later fractions were used in AIH procedures. 
Mann et al. (32), has noted that ejaculate reversal is a 
cause of infertility in some animal species.
4. Semen B i ochemi s t r v Probably the two most
significant events mediated by the secretions of the various 
accessory glands are the coagulation and liquefaction of the 
specimen after ejaculation. Seminal coagulation is not 
observed in males suffering from congenital bilateral 
aplasia of the vasa deferentia and seminal vesicles (33). 
Observations of split ejaculates has shown that the first 
portion of the ejaculated stream does not coagulate at all, 
or, if it does, it liquefies immediately. Terminal portions 
of the stream, on the other hand, do coagulate immediately 
and require much longer periods to liquefy than a normal 
whole specimen. Addition of a portion of the first fraction
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to a terminal portion of the specimen results in rapid 
liquefaction. It is believed that the protein substrate and 
enzymes for coagulation are provided by the seminal vesicles 
while the prostate provides the liquefying agent(s).
The process of liquefaction was initially believed to 
be analogous to the fibrolytic activity of blood (34>. 
However, recent reports show that this is not the case 
(although some blood components are found in HSP) (28, 30,
35-37). Koren and Lukac (36) found that a c o 11agenase-1ike 
protein (CLP) may be responsible for the initial phase of 
liquefaction with further seminal "clot" liquefaction 
attributed to a seminal proteinase.
Table 1 lists some of the common components found in 
semen in association with their probable gland of origin. 
Mann and Lutwak-Mann have noted (5, 17) that some of the
components of seminal plasma are generally considered by 
biochemists to be associated with plants rather than 
animals, particularly fructose, citrate, and
g 1ycery1phosphory1choIine (which is especially abundant in 
potatoes!). In addition, some of the proteins found in 
seminal plasma are associated with intracellular contents 
as opposed to extracelIular material. This can be explained 
(as mentioned earlier) by the fact that apocrine type 
secretions occur in both the prostate and the seminal 
vesicles. This action can also account for the relatively 
large amount of insoluable particulate matter and cellular 
debris observed during microscopic examination of semen.
A great variety of compounds have been identified in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.






(S C , J piece?)
Prostate 15-20 Acid Phosphatase Citric Ac id
Creatinine Kinase Zinc





L i que fac ti on 
Enzymes
PoIyamines
Testes, 7-10 Spermatozoa Transferr in
Ep i d i d y m i s , Phosphorlyglyceryl 
ChoIi ne
Vasa Androgen Binding




Seminal 70-80 Coagulation Enzymes Fructose 
Ves i c 1es
Lactoferrin Prostaglandins
TABLE i. Common Semen Components and Their 
Probable Accessory Gland of Origin
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
18
semen - the listing in Table 1 is far from complete (see
also 26, 38, 39). For the purposes of this discussion,
however, emphasis will be given to some of the major protein 
constituents which may be visualized by electrophoretic
techni q u e s .
Human prostatic acid phosphatase (E.C. 3.1.3.2) is
probably the most widely known and studied enzyme present in 
semen. It was discovered in 1935 by Kutcher and Wolberg (5, 
p. 285) in prostatic secretions and has since been shown to 
be "one of the most important secretory, non-Iysosomal 
products of the prostate gland" (40). Secretion of this 
enzyme is androgen-dependent and its appearance in serum in
increased amounts is indicative of prostatic carcinoma.
Unfortunately, detection of increased serum levels is not 
apparent until the malignancy is well established (41).
Human prostatic acid phosphatase (PAP) is a dimeric
sialoprotein with a molecular weight of 100,000 Daltons. 
The subunits are identical (MW 50,000 Daltons) and have 
carbohydrate compositions similar to other secreted 
glycoproteins. The isoelectric point (pi) varies between 
4.1 and 5.2, with this microheterogeneity being abolished 
upon treatment with neuraminidase to yield a single protein 
with a pi of 6.0 (40, 42). PAP is also a m e t a 11o-enzyme
requiring zinc for activity.
Dermer, Silverman, and Chapman (43) identified a series 
of protein components in human prostatic fluid with a 
molecular mass of around 40,000 Daltons and an acidic pi. 
They have tentatively identified these proteins as the BB
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isozymes of creatine kinase ( CK-BB). CK-BB is present in 
relatively high levels (50,000 ug/L) in prostatic fluid.
Tauber et al. (30) reported that lysozyme is an enzyme 
present in initial fractions of a split ejaculate and thus 
might be prostatic in origin. Lysozyme is a monomeric 
protein with four intra-chain disulfide linkages. It has a 
molecular weight of around 14000 Daltons, and in its native 
state is positively charged with an isoelectric point of 11.
Rosalki and Rowe (44, 45) described a protein present 
in seminal plasma with a distribution similar to that of 
prostatic fluid proteins. This enzyme was determined to be 
gamma-GIutamy1transferase (gGT). They reported that this 
enzyme was present in seminal plasma in levels almost 300 
times greater than are found in blood serum. The molecular 
weight of this enzyme is approximately 80000 Daltons.
Another protein found in the prostate with a lower 
binding affinity for androgens has been variously called 
Prostate Binding Protein (PBP) or Prostatein (46, 47).
Carter and Resnic (48) have recently shown that a component 
of human prostatic fluid closely resembles that of PBP 
identified in rat prostatic fluid. This protein has a 
molecular weight of appro h imate1y 17,000 Daltons and a pi of 
about 5.8.
Human serum transferrin (hTf) is monomeric protein 
capable of binding two atoms of ferric iron. It consists of 
678 amino acids with a molecular weight of 79,500 Daltons, 
and consists of two homologous domains - one associated with 
each metal binding site. There are approximately seven
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disulfide linkages and two asparagine-linked glycans in the 
molecule (49). Transferrin mediates iron exchange in the 
body and is probably one of the major secretory products of 
the Sertoli cells in the testes (50-55).
It has been proposed that, since the so called "blood
testes barrier" (the manifestation of Sertoli cell tight 
junctions) prevents movement of macromolecules such as hTf 
from serum to the tubular lumen, testicular transferrin is 
secreted by the Sertoli cells to serve as a "source of iron
for the heme proteins or for non-heme metalloproteins in 
developing germinal cells" (53).
There has been much discussion about whether or not 
transferrin detected in seminal plasma originates in the 
testes, or other organs like the prostate, or both. If the 
detected Tf is primarily of testicular origin, it may well
serve as a marker of Sertoli cell function (50, 55).
Androgen Binding Protein (ABP) is another important 
protein secreted by the Sertoli cells. ABP is a 
glycoprotein with a molecular weight of approximately 90,000
Daltons. Its production by Sertoli cells in culture is
stimulated by FSH (56). ABP (also known as Sex Hormone
Binding Globulin - SHBG) selectively binds testosterone, and 
to a greater extent, DHT, allowing these androgens to be
accumulated in the seminiferous epithelium and in the
vicinity of differentiating germinal cells (5, p. 94).
Sertoli cell ABP is also responsible for transport of 
testosterone and DHT to the epididymis (5, p. 143).
ABP is also found in the prostate as well as the other
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accessory organs. Again, this protein allows for the 
accumulation of androgen in these tissues so that the 
appropriate steroid hormone/tissue receptor complexes may be 
formed allowing for the regulation of mRNA production and 
thus protein synthesis.
As previously mentioned, LDH-X is closely associated 
with developing spermatozoa. It is primarily a
mitochondrial enzyme with broad substrate specificity. It 
is a tetrameric protein made up of four identical 
testes-specific C subunits. LDH-X is a basic protein with 
an overall molecular weight of 140000 Daltons and a subunit 
weight of between 31 and 38 kDal (13).
Along with providing the bulk of the secretions in the 
ejaculated semen, the seminal vesicles secrete both the 
substrate and enzymes responsible for semen coagulation.
Tauber' et al. (30) reported that lactoferrin (Lf) shows a 
seminal vesicular distribution as well. This glycoprotein 
has a molecular weight of 70000 Daltons, and, like hTf, can 
bind two atoms of iron. Unlike hTf however, the Lf-Fe 
complex is more stable at acidic pHs . The lactoferrin 
concentration in semen is similar to that of human milk. 
These two forms are not identical however <5, p. 280).
B . Semen Analysis.
Andrological evaluation of human semen is often used to 
determine the quality of the specimen produced by a given
individual so that an assesment can be made about his
ability to impregnate his wife. This assesment is generally 
made after repeated or prolonged attempts at conception have
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resulted in a barren union. The goal of semen analysis in 
this instance then, is to determine whether the inability to 
procreate lies with the husband, the wife, or (as is often 
the case) with both.
1. Historical Aspec t s Leeuwenhoek did the first
microscopic analysis of semen in 1677, when he observed 
numerous "seminal animalcules" swimming around along with 
crystals of what later was determined to be spermine. Over
a century later, Vauquelin published a treatis on the
uniqueness of semen in 1791. In the interim, anatomists 
were defining the various reproductive organs in the body: 
William Cowper described the bulbo-urethral glands in 1698; 
Alezis Littre described the urethral glands (1700); and John 
Hunter studied the effects of castration on the seminal 
vesicles and prostate in 1786 (5, pp. 1-10).
The methods of semen analysis have improved 
significantly from these early observations, but progress 
has been slow - due possibly to the nature of the specimen
and the manner in which it is collected. Biblical
injunctions against "spilling of the seed" (Gn 38:11), as 
well as social customs and religious repression no doubt 
have had an influence on the development of assay procedures 
over the centuries, especially in earlier times (57). 
Masturbation is, of course, the method of choice for the 
collection of semen since latex condoms contain agents which 
adversely affect sperm viability, and coitus interuptus 
(withdrawal) is prone to contamination from vaginal 
secretions as well as loss of a portion of the specimen
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( 29) .
2. Trad i t ionaI Semen Ana 1 vs i s In the past, semen
analysis has relied on sperm count, motility and 
morphological studies, and microbial analysis to evaluate 
one's fertility status. Abnormalities found with any of 
these factors may provide the physician with a probable
cause for infertility. Often, no overt abnormality can be 
found, however.
Sperm count has long been used as an indication of 
fertility. An individual is generally considered "fertile" 
if his sperm count falls within a certain range (usually 
20-50 million/milliliter as a lower limit with 250 
million/milliliter as an upper limit). 0 1 igozoospermic
individuals are those whose counts fall below the lower 
limits of normal , while those with counts above that range 
are termed po1yzoospermic. PoIyzoospermia has been
correlated with significant increases in miscarriages and 
other abnormalities in pregnancy <5, p. 71).
Although sperm numbers are important, even Leeuwoenhouk 
noted in 1685, that they must have sufficient viability to
survive in the womb (5, p. 1). Sperm motility and rate of
forward progression are important parameters in semen 
evaluation. Large numbers of non-motile or poorly motile
sperm are hardly conducive to pregnancy. Many factors may
contribute to poor sperm motility: sperm immaturity,
incomplete seminal plasma liquefaction, high post­
liquefaction viscosity, and immunological agglutination, 
just to name a few.
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Semen volume is also as important as sperm numbers. 
Most andrologists consider sperm concentration to be more 
important than total sperm numbers (1>. The fact that the 
spermatozoa are released early in the ejaculatory process 
(as mentioned previously) has led to the successful use of 
initial portions of the ejaculate for insemination 
procedures. These hyperspermic individuals may suffer from 
decreased fertility because of sperm dilution or "washout" 
by terminal portions of the ejaculatory stream. Hypospermia 
decreased seminal plasma volume - can also contribute to 
subfertility by failing to provide sufficient matrix for the 
spermatozoa to attain adequate vaginal placement.
Nest to the physiological adequacy of the spermatozoa 
after successful spermatogenesis, the seminal plasma is
probably the most important factor in determining male 
fertility. It not only serves as a fluid matrix to the 
spermatozoa for physical transport from the male's
reproductive system to the female's, but also serves to
provide nutrients, protection in a hostile environment, 
final maturation and/or capacitation factors, buffering
action, etc. Thus, much information can be gained from 
biochemical analysis of the plasma as well as from the more 
traditional cellular studies performed on the sperm.
3. B i ochemi c a 1 Ana 1 vs i s Biochemical analysis of
seminal plasma has come into greater use in recent years as 
more and more information is gained about the complexities 
of human reproduction. Clinicians have known about the 
value of both qualitative and quantitative determination of
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such components as fructose, citric acid, and acid
phosphatase for more than half a century. More recently,
new and improved methodologies have allowed for the 
determination of a wide variety of substances in ever
decreasing amounts (c.f. Table 1). Immunological assays not
only allow for the determination of antibodies present in 
seminal plasma and blood (such as the FrankIin-Dukes and
Isojima procedures for detecting microagglutination and
sperm immobilization antibodies C5B3), but provide a 
sensitive means of analyzing for other components as well
using specific antibodies coupled with enzyme probes, 
fluorescent markers, or radioisotope labels as a means of 
de t ec t i o n .
Although such procedures have proven to be of great 
clinical value, they are generally time consuming, require
much specimen, and each assay only provides information
about the analyte in question. If the physician desires
information about several different components, a separate 
procedure is usually required for each result requested.
4. H i oh ResoIu t i on Two-Pimens i ona1 Electrophoresis
(HR2DE ) as a, Techni aue for the Ana 1 vs i s o f Semi na 1 P 1 asma 
Protein Cons tit uen t s HR2DE is a technique whereby a small 
volume of seminal plasma (50-100 jil) can provide both
qualitative and semi-quantitative (for the time being at
least) information on all proteins present in seminal plasma 
at a concentration of at least a nanogram per milliliter of 
specimen. This technique can routinly resolve over several
hundred HSP proteins on a single analysis.
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HR2DE is a relatively new technique, being first used 
by O'Ferrell in 1975 (59). Proteins are first separated by 
their isoelectric point in an ampholyte gradient 
polyacrylamide gel under denaturing and dissociating 
conditions. The proteins are denatured to their primary 
amino acid configuration by the actions of 8 Molar urea and 
anionic detergents. Disruption of inter- and intra-chain 
disulfide bonds is accomplished by the addition of the 
reducing substance 2-mercaptoethanoI. The pH gradient is 
established in the cylindrical polyacrylamide gel by the
addition of ampholytes - polyamino sulfonic acids of varying 
chain lengths. The seminal plasma proteins migrate through 
the pH gradient until they reach a point where they are 
electrically neutral, at which point they cease to move and 
form a tight protein band.
After the first dimension separation, the cylindrical
gel containing the separated HSP proteins are then mounted
orthagonally to SDS-po1yacry1 amide concentration gradient 
"slab" gels for a second separation based on protein size. 
The anionic detergent sodium dodecy1s u 1phate (SDS) causes 
the denatured protein to be surrounded with a uniform 
negative charge so that the primary separating force in the 
second dimension is the sieving action of the gradient gel 
rather than electromotive attraction. The resulting
two-dimensional gel - or e 1ectropherogram - is then stained 
by various techniques for visualization of the separated 
proteins. In 1977, and 1978, Anderson et al. published 
further refinements to this technique (dubbing it the
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ISODALT technique) and proposed its use as a method suitable 
for the ambitious task of mapping the entire human genome
(60-63 ) !
To date, slight variations to this technique have been 
used by numerous researchers to analyze the protein 
constituents in complex biological specimens such as blood 
serum (60), urine (64-66), cerebrospinal fluid (67), cell 
lysates (68, 69), and tissue homogenates (70). Our
laboratory adapted this technique for the analysis of human 
seminal plasma between 1979 and 1980 (71, 72). Edwards,
Tollaksen and Anderson (73) used their ISODALT procedure
along with the EASODALT procedure of Willard et a l . (74) to
look at the effects of liquefaction on seminal plasma
composition in 1981. Their ISODALT procedure produced
seminal plasma protein distributions very similar to ours. 
In their report they described a series of basic proteins 
which they could observe in the ISODALT gels but were better 
resolved with the BASODALT technique. These proteins were
observed to disappear with time and it was proposed that
they were associated with semen liquefaction. In addition, 
they described another group of proteins ("Group A") that
they believed were associated with testicular secretions, 
since they appeared to be absent in the semen of a limited 
series of post-vasectomy donors when compared with "normal" 
semi nal p I a s m a . .
Carter and Resnic (48) as well as Dermer et a l . (43)
used two-dimensional electrophoresis to investigate the 
protein content of prostatic fluid in 1982, with the
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identification of some of the proteins mentioned previously 
(e.g. PBP, CK- B B , e t c .).
A recent search of the available literature has found 
few others who are doing work in the area of whole seminal 
plasma electrophoresis. Thus, the field is ripe for
continued work in this area.
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11 . STATEMENT OF PURPOSE
It has been the purpose of this project to provide a 
method of seminal plasma analysis providing comprehensive 
biochemical information about the protein components in 
human semen which may possibly impact on patient fertility. 
Existing techniques currently only provide information about 
individual seminal plasma constituents - generally with a 
separate analysis required for each component requested. On 
a single analysis however, High Resolution Two-Dimensional 
Electrophoresis (HR2DE) is capable of simultaneously 
resolving over several hundred seminal plasma components.
The goals of this study have been to a.) establish a 
"normal" seminal plasma protein distribution pattern in the 
resulting two-dimensional e 1ectropherogram, b.) to observe
the effects of semen coagulum liquefaction on the 
distribution of proteins in the seminal plasma
electropherograms with respect to time, c.) to differentiate 
the proteins in the e 1ectropherogram according to their 
accessory organ of origin, and d . ) to observe protein
differences associated with several classes of subfertile or 
infertile individuals.
Hopefully, the information presented here will allow
the Andrologist and other clinicians to gain a better
insight into the pathophysiology associated with reduced
29




which, when properly managed, may ultimately lead 
I rates of conception in a given individual.
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H I .  EXPERIMENTAL TECHNIQUES
A . Mat e r i a 1 s
Acrylamide, N ,N 1-methyIene-bis-acry1 amide, Coomassie
Brilliant Blue CCBB) R-250, glycine, 2-mercaptoethanoI,
sodium dodecyl sulfate (SDS>, and urea were obtained from 
Sigma as were purified human transferrin and lactoferrin. 
Electrophoresis grade agarose and BioLyte (3/10, 7/9, and
S/7 range ampholytes) as well as the High and Low Molecular 
Weight Protein Standards were obtained from BioRad. Eastman 
Kodak was the source of N ,N ,N 1,N '-tetramethyIethy1- 
enediamine (TEMED) and the tracking dye bromophenol blue
(BPS). Nonidet P-40 (NP-40) was purchased from Particle
Data Labs, L t d . . Purified IgA and IgM were obtained from 
Cappel Laboratories, Inc.. Purified mouse LDH-X was a gift 
of Dr. C. Y. Lee. All other reagents were analytical grade
qua 1i t y .
B . Eoui ament
Sample centrifugations were accomplished using a IEC 
clinical centrifuge for low-speed semen centrifugations or 
an Eppendorf 5414 Microfuge for high-speed separations. A
Scientific Products Temp Blok Module Heater was used for 
heat denaturation of seminal plasma specimens.
First dimension IEF separations were carried out in
31
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locally cut 4 mm ID borosilicate glass tubing in a Hoe £ e r 
Scientific Instruments Electrophoresis Chamber, Model 
DE-10 2. Second dimension separations were accomplished in 
chambers that were locally fabricated according to 
specifications given in Appendix A. This design offered no 
significant advantages over commercially produced or 
otherwise available models eacept that they were less 
expensive to produce.
Acrylamide gradients were cast with the use of a 
Pharmacia GM-1 gradient mixer and a Technicon Auto Analyzer 
Proportioning Pump fitted with 1.0 ml/min pump tubing 
(green-green) set up as shown in Appendia A 2 .
An E-C Apparatus Corporation Model E-C 400 Power Supply 
was used for all electrophoretic separations.
C . Human.Subjects
The majority of the semen specimens used during the 
course of this study were considered "eacess specimens" in
that they were produced under orders of a physician for
other diagnostic purposes (usually a basic semen analysis).
A normal ejaculate has a volume of between three and five 
milliliters. A basic semen analysis generally requires less 
than one milliliter to complete: the remaining specimen is
generally discarded. Instructions were given to the
technologists in the laboratories cooperating with this 
study on how to treat any semen remaining after the
requested analysis had been completed.
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Permission was solicited <75) and obtained (76) from the 
Old Dominion University Institutional Review Board for the 
Protection of Human Subjects to use both volunteer and paid 
donors to obtain semen from proven fertile individuals. 
These donors provided the semen used to establish normal 
e1ectropherograms and for the specialized collection 
techniques (i.e. timed specimens and split ejaculates) 
(proposal). These individuals were advised of the nature of
the project as well as the method of semen collection, and 
were required to sign an informed consent form and complete 
a short questionnaire (see Appendia B) before a specimen was 
collected. All information on these individuals was kept 
conf ident i a l .
D . Me thods
1. Sample Collection.
a. Whole Semen: Semen was collected by masturbation
into a 50 mL screw-top, polypropylene, conical centrifuge 
tube. These tubes were acid washed with 5% nitric acid (if 
subsequent trace metal analysis was to be performed) or 
sterile (if microbial determinations were indicated).
Explicit collection instructions were given in Appendia B 5 . 
After collection, individuals were instructed to deliver the 
specimen to the laboratory within one hour. The individuals 
were also instructed to accurately note the time of 
collection, whether or not any semen was spilled, and the 
length of time since the last ejaculation.
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b. Time Study Experiments: Individuals
participating in time study experiments were instructed to
collect the specimen as noted above in the Andrology Lab 
collection room so that it could be delivered to the lab 
within five minutes of collection. The donor started a
stopwatch at ejaculation so that accurate time intervals for 
denaturation could be maintained.
c. Split Ejaculates: Several methods of collecting
split ejaculates were evaluated. The first few specimens
were collected by masturbating into a large (345 mm s 225 m m  
x 5 0 mm) Pyrex dish that had been divided into sections so 
that individual segments of the ejaculated stream (i.e. 
"spurts") could be sampled for sequential analysis.
Subsequent specimens were collected into an acid washed
polystyrene six-well Costar Tissue Culture Cluster
(microtiter plate), Cambridge, M A . These containers were
not only more convenient, but had integral covers to prevent 
evaporation loss and contamination.
d. Urethral Gland Secretions: In certain
individuals, it was possible to collect droplets of
pre-ejacuI atory fluid (i.e. urethral gland secretions) after 
sufficient sexual arousal. These secretions were collected 
in a 1.5 mL microcentrifuge tube and delivered to the lab 
with the whole semen specimen.
e. Prostatic Fluid: Occasionally, it was possible
to obtain prostatic fluid in the course of urological
examinations. These secretions were collected by a
urologist in a 1.5 mL screw-cap microcentrifuge tube and
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frozen immediatly.
f. Epididymal Plasma: In the course of vas
deferens transection (during vasectomy) several attempts
were made to collect small amounts of testicular fluid from 
the vaso-lumen either proximal or distal to the cut using 
sterile 50 ul capillary tubes. This technique was
unsuccessful however.
2. Semen Analysis Once received in the laboratory,
patient specimens were subjected to standard semen analysis 
procedures as described elsewhere <29, Appendix C ) . These 
procedures included noting physical characteristics (volume, 
color, state of liquefaction, pH), sperm count, motility
studies, live-dead ratio, microbial analysis (where
indicated), and morphology studies. Approximately 90
minutes after the noted collection time, 300 jiL of the
specimen were removed (using metal-free pipet tips) and 
transferred into an acid-washed 1.5 mL microcentrifuge tube. 
This aliqout was centrifuged at low speed (less than 300xg) 
for five minutes to separate sperm cells and debris from the 
seminal plasma. One hundred microliters of seminal plasma 
were removed and placed in a microcentrifuge tube containing 
lyophilized denaturing reagent (described in next section). 
After the reagent dissolved, the specimen was stored at 4°C 
for subsequent analysis. The remainder of the specimen was 
used for other research projects.
Timed donor specimens were denatured at five minute 
intervals after the noted collection time by placing the 
specimen directly into the microcentrifuge tube containing
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the lyophilized urea/SDS mixture without first separating 
the spermatozoa from the seminal plasma. After denaturation, 
the specimens were subjected to high-speed centrifugation 
(15000 k g) for two minutes and the supernatant seminal 
plasma withdrawn for electrophoresis.
The volumes of the individual portions of the split 
ejaculates were measured along with pH and, when possible, 
100 ul were removed from each fraction for trace metal 
analysis as well as a portion for sperm count. One hundred 
microliters were removed from each fraction for denaturation 
and electrophoresis.
3. Seminal Plasma Denaturation : A denaturing solution 
was prepared containing 8 mol/L urea and 2% (w/v) sodium 
dodecyl sulfate (SOS). This solution was dispensed in 125 
uL aliquots into individual 1.5 mL screw-cap microcentrifuge 
tubes. These tubes were frozen at -70°C for several hours 
and then lyophilized. After 1yophi1ization, the tubes were 
stored at 4° C until use. To reconstitute, 100 of seminal 
plasma were added with vortexing to dissolve the pellet. 
The specimen could again be stored at 4°C or subjected to 
subsequent procedures. Just prior to electrophoresis of the 
specimen, 20 jiL of 10% Nonidet F-40 (NP-40) and 5 pL of
2-mercaptoethano1 (BME) were added to the sample followed by 
heating at 95e C for five minutes. After cooling, the 
specimen was ready for application to the isoelectric 
focus ing gel.
4. Isoelectric Focusing (IEF) : IEF gels were prepared 
in 135 mm z 4 mm ID glass tubing sealed at one end with
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Parafilm. The gel solution was prepared to contain 8 mol/L 
urea, 2% Cv/v) NP-40, 2% w/v ampholytes (60% Biolyte 5-7:20% 
Biolyte 7-9: 20% Biolyte 3-10), and 40 g/L acrylamide
monomers (38.0 g/L acrylamide and 2.0 g/L N , N ‘-me thy 1ene- 
bis-acryI a m i d e ) . Polymerization was initiated by adding 7 
mg of ammonium persulfate (APS) and 2.5 jiL of 
N , N ,N' ,N 1 - tetramethyIethy1enediamine (TEMED) per gram of 
total acrylamide monomer. After casting the gels, they were 
overlayered with water saturated n-butanol to minimize air 
contact and surface distortion.
Once the gels polymerized, they were assembled into 
the electrophoresis chamber and each cylinder overlayered 
with 8M urea/2% SDS. The gels were then prefocused for 15
minutes at 200 v (constant voltage), 15 minutes at 300 v, 
and 30 minutes at 400 v. The cathode solution was 0.02 
mol/L NaOH with 0.01 mo 1/L phosphoric acid at the anode.
After prefocusing, the urea/SDS solution was removed 
from the gel tubes and 40 /iL of denatured specimen were 
applied. The gels were then e 1ectrophoresed for
approximately 11,000 volt-hours with the final hour being at 
950 v to sharpen the focus. After focusing, the gels were 
extruded from their tubes for subsequent procedures.
5. IEF Gel Equilibration After removal from the
focusing tubes, the IEF gels were placed in glass sample 
tubes with approximately 2 mL of equilibrium buffer (10% w/v 
glycerol, 5 % v/v B M E , 2% w/v SDS, and 0.0625 mol/L Tris
chloride, pH 6.8) for approximately five minutes. After
equilibration, the gels were removed from the buffer,
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blotted with lint-free filter paper and affixed to the SDS
slab gel as described in paragraph III.C.8.
6. pH  Profile One gel per IEF run was left blank
for pH profiling. After electrophoresis, this gel was
removed from its tube and cut into 10 mm segments. Each 
segment was added to 2.0 mL of deionized water and allowed 
to equilibrate for six hours at room temperature. After
this time, the pH of each segment in solution was determined
using a standard pH meter. This data was plotted with pH 
versus 1 eng t h .
7. The Second Dimension SDS Slab Gel Linear gradient
slab gels were cast wi t"h acrylamide concentrations varying 
from 170 to 70 g/L. These acrylamide solutions were 
prepared from a stock 300 g/L acrylamide solution (285 g/L 
acrylamide and 15 g/L bis-acry1 amide) and made up to contain
1.0 g/L SDS and 0.375 mol/L Tris (pH 8.8). A 1.5 cm stacking 
gel containing 4.0 g/L acrylamide, 1.0 g/L SDS and 0.125
mol/L Tris (pH 6.8) were immediatly overlayered on the 
unpolymerized gradient gel. This allowed both gels to
polymerize simultaneously preventing separation of the 
stacking gel from the resolving gel. Polymerization of both
gels was initiated by the addition of 1.1 mg APS and 1.75 jiL
of TEMED per gram of total acrylamide monomer in solution. 
After casting, the gels were again overlayered with water
saturated n-butanol. After polymerization (within two
hours), the butanol was rinsed from the top of the gel and 
replaced with stacking gel buffer diluted 1:4 to remain
overnight (while the first dimension separation was being
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accomp1i shed > .
8. Preparation for the Second Dimension Separation
The slab gel chambers were prepared for electrophoresis by
removal of the sealing gaskets, and rinsing both the upper
and lower gel surfaces with deionized water. The upper 
surface was then blotted dry and covered with molten agarose 
<1% in equilibrium buffer) to prepare a bed to receive the 
equilibrated IEF gel. The IEF gel was then placed on the 
agarose bed (origin to the right) and sealed in place with 
additional hot agarose. Molecular weight markers were
prepared by adding commercially produced standard protein
mixtures to the molten agarose (0.2 g/L). This solution was 
drawn up in a 100 pi. capilary and allowed to solidify.
After cooling, the mixture was extruded from the capilary
and 5 mm segments were sealed in place on the slab to the
right of the IEF gel.
9. Slab Gel Electrophoresis Chilled electrophoresis
buffer (0.025 mol/L Tris, 0.192 mol/L glycine, and 0.1% w/v 
SDS) was added to both the upper and lower electrophoresis
chambers. Separations were carried out at 4 C between 20 
and 25 mA constant current per gel. Electrophoretic
progress was monitored by the addition of 0.05% w/v
bromophenol blue to the cathode buffer compartment. 
Separations were terminated when the tracking dye reached 
the bottom edge of the slab gels (usually within 6.5 hours).
10. Protein Visualization After electrophoresis, the
slab gels were removed from the glass plates and fixed in
staining solvent (50% v/v methanol, 10% v/v acetic acid) for
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3-15 hours. The gels were then stained for two hours in 2.0 
g/L Coomassie Brilliant Blue R-250 (CBB R-250) in staining 
solvent, destained for 2-3 hours in full strength staining
solvent, and then again in ha If-strength staining solvent
until the desired background color was obtained. The gels
were then stored in deionized water in Zip-Lock freezer 
bags .
11. Protein Pattern Interpretation The stained
two-dimensional gel slab, or electropherogram, can be read 
like a cartesian graph with the vertical axis representing 
increasing molecular weight (in Daltons) and the horizontal 
axis representing increasing pH. Selected protein
components were identified by comparison with previously 
published data (43, 48, 52, 60, 71, 73) or by
co-electrophoresis of purified proteins (see Appendix D-79). 
Each gel was traced and photographed for comparison with 
other seminal plasma specimens. A composite map was 
constructed from seminal plasma maps of those individuals 
who were known to be healthy and fertile. Pattern alignment 
enabled detection of variations in protein locations 
(relative to albumin and acid phosphatase, for example) 
between seminal plasma specimens. Comparison of maps from 
the different patient types, or seminal plasma fractions, 
allowed for the determination of which groups of components 
in the total protein map were contributed by the various 
accessory organs.
12. Photography All eIectropherograms were
photographed using Kodak Plus X 35 mm black and white film
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(ASA 125) through a Tiffen green #1 filter. Exposures were 
generally taken with backlighting provided by 20 W
Vestinghouse Agro-Lite fluorescent lamps at f 11 at 1/15 
second. Gel tracings were photographed in sunlight using 
high contrast Kodalith film or reproduced on 3M reversed 
image transparency film.
Hfr.St.
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IV. RESULTS
A . Time Course Studies.
Initial studies were carried out to investigate the 
changes in HSF proteins with respect to time so that an 
optimal sampling time could be established allowing for a 
consistant comparison between patient specimens. Since the 
majority of the specimens used in this study were produced 
for purposes other than ours, it was not possible to collect 
the specimen into a solution which would inhibit semen 
liquefaction or proteolytic activity thus allowing for a
more carefully controlled analysis of seminal plasma
prote i n s .
Evaluation of seminal plasma using the HR2DE technique 
showed that very few changes could be observed in the 
specimen after about 60-90 minutes. This is consistent with 
the work of others (35-37>, and the fact that gross 
liquefaction is essentially complete after 15-20 minutes.
Thus, it was decided that all patient specimens would be 
denatured at appro k imate1y 90 minutes after collection. 
This allowed for ample transportation time to the laboratory 
(patients were instructed to deliver the specimen to the lab 
within one hour of collection) and for preparation of the 
sample (i. e. centrifugation) prior to denaturation. This 
depended heavily on the patient's honesty in accurately 
reporting the time of collection.
42
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In volunteer donor studies, it was possible to 
accurately control the time of collection since these 
individuals were willing to cooperate more closely with the 
needs of the program. Collection of the specimen in a room 
in the immediate vicinity of the laboratory allowed for 
receipt of the specimen within two to three minutes of 
ejaculation. By denaturing aliquots of the specimen at 2.5- 
5 minute intervals after collection with subsequent 
two-dimensional analysis, it was possible to observe the 
effects of liquefaction on the seminal plasma protein 
const i tuents .
Figure 3 shows the effects of time on the distribution 
of proteins in a representative specimen (SE02). It can be 
seen that there are several series of basic proteins along
the right gel margins with molecular weights ranging from
45-65 fci 1 o-Da 1 tons (IcDal) that rapidly disappear as 
liquefaction progresses. These proteins are essentially 
absent after about 20 minutes, but in one specimen (SE07) 
were gone in less than ten minutes. This rapid disappearance 
of proteins was also reported by Edwards, et al., (73) using 
their non-equilibrium BASODALT technique. These basic 
"coagulation" proteins correspond well with those proteins 
emitted in terminal portions of the ejaculate that are 
associated with seminal vesicle secretions (as discussed in
subsequent paragraphs). As time progresses, the higher
molecular weight proteins beginning with a protein
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designated CP 1 (M. W. 63-65 kDal) give way to a series of
progressively smaller fragments differing by about 5 kDal 
<CP 2 = 57.5 kDal, CP 3 = 52.5 kDal, and CP 4 = 47.3 kDal). 
Series CP 5 and 6 <37-40 and 18.1 kDal) do not disappear as 
rapidly as the others, but are essentially absent after 45 
minutes. Series A is not associated with the liquefaction 
process since it appears in relatively constant amounts 
throughout the time observed and can be observed in most 
specimens after periods of 90 minutes or more. Series CP 7 
and CP 8 (15.3 and 14.5 kDal respectively) appear to
increase slightly with time, but the magnitude of increase 
does not necessarily correlate well with the disappearence 
of the other proteins.
B . So 1it- Ejacu1 ate Studies.
Much information was gained from this series of
experiments. The donors, on a whole, experienced little 
difficulty in using the six-well Costar culture plates for
specimen collection: only one individual was unable to
produce more than three fractions - all others were able to 
distribute their ejaculates into six or more fractions. 
Table 2 gives an example how the seminal plasma volume and 
spermatozoa were distributed between the various fractions 
as well as the pH of each fraction (measured with Hydrion
Paper), and distribution of zinc (77). These data correlate 
well with the findings of others (24-30) in that the bulk of 
the spermatozoa are emitted in the initial portion of the 
ejaculate. In addition, the high levels of zinc and other
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Specimen SE03










1 7 . 0 0 . 55 12 . 2 320 63 . 0 164
2 7 . 5 0 . 81 18.1 90.1 23 . 6 149
3 8 . 0 0 . 77 17.1 5 . 2 1 . 4 98
4 8 . 0 1 .24 27 . 7 18.2 4 . 8 51
5 8 . 0 0 . 54 12.1 4 . 1 1 . 1 24
6 8 . 0 0 . 57 12.7 1 . 9 0 . 5 14
To ta 1 
or 
Ave
COV 85 . 0 82
TABLE 2. Comparison of Various Parameters in a Split
Ej acula te.
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components such as acid phosphatase in the initial fractions 
confirms that these secretions originate in the prostate as 
previously reported (39).
Comparison of electropherograms of first fraction 
components with prostatic fluid (collected by prostatic 
massage) shows that there is a good correlation of proteins 
suggesting that the very first portion of the ejaculate is 
predominately prostatic in origin (see Figure 4). Of
particular interest is the presence of the well-known
prostatic marker protein acid phosphatase (PI), which can be 
seen to quantitatively decline in subsequent fractions (see 
Figure 5). This protein was previously identified by our 
laboratory (71) by co-electrophoresis of the purified 
enzyme. Several other proteins are observed to be primarily 
prostatic in origin as well. These are designated P2-P4 in 
Figures 4 and 5. The P2 series shows the exact same
relationship to albumin and acid phosphatase as the protein 
proposed to represent the BB-isozyme of creatine kinase by 
Dermer et al. (43). These proteins decrease slightly in 
quantity as the ejaculation sequence progresses, but are 
still present in significant quantities in terminal portions 
of the ejaculate. Proteins P3 and P4 exhibit a similar 
prostatic distribution. These proteins (M. W. 16.2 and 17.8 
kDal) were observed by Carter and Resnic (48). They 
determined that F4 was analogous to Prostatic Binding 
Protein from the rat ventral prostate (46). They also 
observed that P3 diminished in quantity with increasing age.
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A comparison of the e 1 ectropherograms of seminal plasma 
proteins from the various fractions of a representative
split ejaculate is given in Figure 5. One can readily
observe considerable differences in the distribution of 
proteins between the initial and terminal portions of the 
ejaculate. Terminal fractions can be associated with
seminal vesicle secretions. As previously discussed, the 
seminal vesicle secretions are responsible for liquefaction 
of coagulated semen. As previously shown in Figure 3, these 
basic proteins (designated CPI-8) rapidly disappear in 
conjunction with the dissolution of the seminal clot in the 
whole specimen. Terminal split ejaculate fractions do not 
rapidly liquify however, since they are isolated from the
initial portions of the ejaculate containing the proteolytic 
enzymes contributed by the prostate. Fractions 5 and 6 have 
been observed to remain coagulated for up to two hours. 
Subsequent addition of 100 jul of semen from fraction 1 
causes rapid liquefaction (within ten minutes) of these 
terminal fractions.
As can be observed from Figure 5, there is a continual 
increase in the lower molecular weight proteins ranging from 
10-25 kDal as the ejaculation sequence progresses. In the 
initial fraction there are only three to four major proteins 
(i. e. P3 and P 4 ) present as compared with almost 30 protein 
spots of the same approximate spot intensity in the same 
area of the terminal fraction.
A heterogeneous series of proteins designated "L" are
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present in all fractions of the ejaculate with an apparently 
slightly greater concentration in the terminal fractions. 
These proteins fall in an area identified as the 
immunoglobulin light chains i K  and/)) by co-e 1 ec t ropho res i s 
of the purified proteins (see Appendix D-79A and D-79B). In 
addition, a protein band labeled -r- is observed primarily 
in fractions 1-5; these being most predominant in fraction
2, and only slightly visible in fractions 6-8. These
proteins may represent the Y -  chains of IgG (see Appendix
D-79B). An anomaly that can not be explained is the
presence of increased amounts of heavy chains in the 
terminal fractions of the ejaculate without a concomittant
increase in light chains. Other split ejaculate series
(Appendix D-67 to D-72) exhibit varying amounts of the heavy 
chain with relatively constant amounts of protein in the 
light chain area.
A series of three to four basic proteins labeled "A" 
have an average molecular weight of 27,000 Daltons. These 
proteins migrate in the same area as the C monomers of
purified LDH-X when run alone and co-e1ectrophoresed with
HSP (see Appendix D-79E and C13, 143). Another set of
proteins present in all but the initial fraction, in this 
case, are the two prominant proteins in the 34-40 kDal 
molecular weight range labeled "B". These two proteins are 
joined by a whole series of like-weight proteins arranged in 
vertical columns or palisades as the ejaculate sequence 
progresses (series B 1 in Fraction 8). Series C, an acidic
group of proteins with an average molecular weight of 80.3
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kDal, is also observed in all fractions, but in increased 
amounts in terminal portions. A protein previously
identified <71) as albumin (Alb) is also present in the 
initial or prostatic secretions, with concentrations 
decreasing significantly as the ejaculation sequence 
progresses. Transferrin <hTf) appears to increase in 
fractions 1-3 and then decrease in fractions 4 and 5, with 
little observed in fractions 6-8. This correlates well with 
the premise that hTf is produced primarily by the Sertoli
cells and thus its detection is in conjunction with
distribution of testicular secretions and spermatozoa from
the ampullary glands. Lactoferrin (Lf) was reported by
Tauber et al. (28) to follow a seminal vesicle distribution. 
One can observe that in this sequence, Lf is present in all 
fractions with increased amounts in the terminal portions of 
the ejaculate. The locations of transferrin and lactoferrin 
were identified by electrophoresis of purified proteins 
(Appendix D-79C and D-79D).
C . Other Seminal Fractions.
As mentioned in Chapter III, isolation of 
testicu1a r /epididymaI secretions from the vas deferens 
during vasoligation procedures was unsuccessful. Seminal 
plasma differences between "normal" and vasectomized 
individuals will be discussed in subsequent paragraphs.
Numerous researchers (c.f. 26, 37) have reported the 
presence of large "sago-" or "tapioca-1 ifce" globules upon 
macroscopic observation of freshly ejaculated semen. These
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globules gradually disappear as liquefaction proceeds, but 
persist if liquefaction is incomplete or delayed. They are
also observed to be present in greater quantities in
terminal portions of the split ejaculates, but in some cases 
(e. g. SE03), were present in initial portions as well. 
Some of these globules were isolated from less than five
minute old semen and from incompletely liquified specimens
and were washed in several changes of normal saline to 
remove seminal plasma contaminants prior to denaturation.
Microscopic observation of these globules revealed that they 
were not membrane bound, but resembled the fiberous coagulum 
observed by Tauber and Zaneveld (37). Analysis by HR2DE 
gives rise to e 1ectropherograms as shown in Figure 6a. When
comparing this e1ectropherogram with those representing 
terminal fractions of the split ejaculate (Figure 6b>, one 
can see that these globules most likely represent "packets" 
of seminal vesicle proteins which have not yet been invaded 
by proteolytic enzymes from prostatic (or first fraction)
seere t i o n s .
HR2DE analysis of Pre-EjacuIatory Fluid (PEF) yielded 
results as shown in Figure 7. The relatively high molecular 
weight, acidic distribution of these proteins is strikingly
different from that of whole seminal plasma. This 
distribution is characteristic of mucoproteins containing 
large numbers of sialic acid residues (59, 64). Series D on
the acidic margin of the gel (pi 4.1-4.5) has a molecular 
weight ranging from 43.6-45.5 kDal and may correspond to
acid glycoprotein as identified by Anderson (60).
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FIGURE 6. Comparison of Washed "Globules" from Non-Liqui- 
fied Semen and a Terminal Fraction of a Split 
Ejaculate.
FIGURE 7. E 1ectropherogram of "Pre-EjacuI atory Fluid
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a. Washed Globules b. Split Ejaculate
Fraction 6
tuaoffiHGtB
FIGURE 6. Comparison of Washed "Globules" from Non-Liqui- 
fied Semen and a Terminal Fraction of a Split 
Ejaculate.
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Series E corresponds with the immunoglobulin light 
chains and , while Series F (molecular weight 58.9-61.7 
JcDal) corresponds with the heavy chain (see also Appendix 
D-62). The area marked "G" represents a high concentration 
of a single protein ranging in molecular weight from
58.9-64.5 kDal. Series H are negatively charged proteins 
with a molecular weight of around 30,000 Daltons.
D . "Normal" Volunteer Studies.
Figure 8 represents a composite map of post­
liquefaction proteins common to the HSP produced by
individuals with recently proven fertility. Proteins other
than those designated with roman numerals are labeled as
identified in previous discussions.
Series I has a molecular weight of 35,000 Daltons and
is present in most normal electropherograms observed with
notable exceptions. Series II proteins are acidic, low 
molecular weight (10-20 kDal) proteins which differ in
amount and location from individual to individual and may be 
primarily prostatic in origin. This group contains the
proteins P3 and P4 previously discussed.
Series III proteins form very characteristic
constellations of spots in most specimens. These proteins 
are arranged in vertical stacks with the lower portions 
skewed to the acidic edge of the gel forming characteristic 
"J" shaped patterns in the gel. Series IV contains another
very heterogeneous set of proteins contributed primarily by 
the seminal vesicles, again differing both in quantity and
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FIGURE 8. Composite Map of Post-Liqoifsction Seminal Plasma 
Proteins from Individuals with Recently Proven 
Fertility: Alb = Albumin; hTf = Transferrin;
Lf = Lactoferrin; aAT = a Ipha-1-Antitrypsin; CP 
1-8 = Coagulation Proteins (from seminal 
vesicles); A = Lactate Dehydrogenase isozymes 
(including LDH-X); B ‘ = Seminal Vesicle 
Proteins; C = gamma-GIutary1transferase (gGT);
= IgG Heavy ( ) Chain; L = Immunoglobulin Light
Chains ( and ); PI = Acid Phosphatase 
Isozymes; P2 = Creatine Phosphatase-BB; P3 = 
Lysozyme <?); F4 = Prostate Binding Protein 
(PEP); I = Testicular Protein; II = Variable 
Region; III = Characteristic "J"-shaped Proteins 
(from Seminal Vesicles); IV = Variable Region 
(from Seminal Vesicles); V = Variable Region 
containing Subset L; VI = Variable Region 
containing Subset ; VII = High Molecular Weight 
Proteins associated with Sperm Count.
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FIGURE 8. Composite Map of Post - Liquifaction 
Seminal Plasma Proteins from Indivi­
duals with Recently Proven Fertility
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location from individual to individual. Series V proteins
contain the subset L , or immunoglobulin light chain
proteins as well as other proteins contributed by both the 
prostate and seminal vesicles. Series VI are neutral to
basic proteins with molecular weights ranging from 45-6
kDal. This group also shows a great deal of variation in
both quantity and location of proteins from specimen to
sp ec i m e n .
Series VII are acidic, high molecular weight proteins 
ranging from 100- to over 200 kDal in size. The location of 
these proteins with respect to albumin and PAP is fairly 
reproducible. They are heterogeneous and usually only
present in trace amounts except as noted below.
E . Patient Studies.
1. Azoospermic Pat ients Figure 9 shows a composite
of e I ectropherograms from three different azoospermic
patients. The specimen producing the gel represented in 
Figure 9a (RS012>, came from an individual suffering from 
pan-testicu1 ar failure as a result of radiation treatment 
(10 days) and Bleomycin therapy (11 months) for Hodgkin's 
Disease. Seminal plasma analysis presents a fairly normal 
distribution of proteins in the gel. This is to be expected
since the aforementioned therapies generally only affect
germinal tissue function resulting in a lack of spermatozoa 
production, with most other reproductive functions remaining 
normal (78). A notable protein difference is the lack of 
the series I proteins mentioned above.































































































































Figure 9b was produced from seminal plasma collected 
from an individual (RS015) who had undergone a 
Trans-Urethra1 Resection (TUR) procedure for a congenitaly 
blocked ejaculatory duct. This pattern is grossly abnormal 
when compared to Figure 8, but is reasonably comparable to 
the prostatic fluid map given in Figure 4. This is to be 
expected since all secretions proximal to the ejaculatory 
ducts are blocked. The abnormalities observed in the
locations of FI and P2 are not due to overloading or 
distortions in either of the acrylamide gels since this 
pattern was reproduced in two different separations run on 
separate occasions. F4 (Rosalki and Rowe's Frostatic
Binding Protein) is present in greatly increased amounts.
Hissing from the pattern is transferrin - a Sertoli cell
product.
Specimen RS052 in Figure 9c, was produced by a patient 
in whom no vasa deferentia could be palpated on scrotal 
examination. As in Figure 9a, this pattern is relatively
normal. Transferrin appears to be present in the sample, as
well as some evidence of coagulation proteins along the 
right-hand margin of the gel.
2. Post Va sec t omv Pa t i ent s Specimen RS053 was
produced by an individual who had undergone elective
sterilization via vasectomy several months prior to this
analysis. This individual had previously fathered two 
children. A relatively normal distribution of HSP proteins 
can be seen in Figure 10a. Series VII proteins appear to be 
more pronounced in this and other post-vasectomy specimens
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analyzed as compared to normal individuals. Series I 
appears to be present in this specimen.
Figure 10b shows a map of seminal plasma from an 
individual (RS049) with Peyronie's Disease who had undergone 
a bilateral vasectomy in conjunction with a right
epididymectomy in November of 1981. This was necessitated 
by the formation of an epididymal abcess subsequent to a 
bout of epididymitis. A small right hydrocele developed 
around the right testicle after surgery and was aspirated in 
December, 1982. The specimen was collected five months
later in Nay, 1983.
One can observe a striking absence of the low molecular 
weight series II and series III proteins yielding a pattern 
similar to that of prostatic fluid. The series B vesicular 
proteins are present, however, as are CP7 and 8. The series 
A proteins appear to be present in multimeric forms or in 
conjunction with a series of proteins with similar 
electrophoretic characteristics (CP5 ?). A band of proteins 
in the series VI region is greatly enhanced as are proteins 
in series VII. Series I is not observed to be present.
A third patient in this series (RS010) had undergone a 
vaso-vasostomy (vasectomy reversal) three weeks prior to the 
collection of this sample in an attempt to regain his 
fertility. The procedure was evidently successful, since 
spermatozoa were observed in the specimen <18 million/ml). 
The specimen was moderately viscous however, with
non-specific clumping observed. The e 1ectropherogram is not
of the best quality, but never the less shows a relatively
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normal distribution of proteins with the exception that 
series VII is enhanced. It is not possible to determine if 
series 1 is present or not due to the quality of the gel.
3. Varicocele Patients Results from varicocele
studies are difficult to interpret in that these individuals 
presented a whole spectrum of results ranging from small 
left varicoceles with normal semen parameters to severe 
oligozoospermia (less than 5 million sperm/ml), or 
varicoceles with additional complications such as 
epididymitis or pyuria. In addition, there was another
group of patients who had undergone varicocelectomy
(spermatic vein ligation) anywhere from two to ten months
priot to analysis.
Figure 11 gives a representation of seminal plasma from 
a small left varicocele patient with normal sperm parameters 
(lla); a patient with a small left varicocele and severe
oligozoospermia (lib); a patient with a large left 
varicocele (complicated with left testicular atrophy) and 
severe oligozoospermia (11c); a five month post­
varicocelectomy patient with moderate oligozoo- spermia
(lid); a seven month post-operative patient with severe 
oligozoospermia (lie); and a post- bilateral varicocelectomy 
patient whose wife subsequently became pregnant (Ilf).
Series VII proteins appear to be increased in 
practically all of these patients - especially in the
severely o 1 igozoospremic patients (lib, c, e, and d).
Series I proteins were not observed in any of the varicocele 
specimens except RSQ18 and RS030 (lla and d) which were only
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moderately o 1 igozoospermic.
Specimen RS018 (lla) demonstrated a remarkable
heterogeneity in the series A proteins (although the higher 
molecular weight bands may represent incomplete liquefaction 
of CP5). The series VII proteins are present in quantities 
similar to those in normal individuals (i. e. only slightly 
visible - as opposed to the discrete spots observed in 11c).
Specimen RS019 (lie), shows increased amounts of
transferrin, whereas hTf is only faintly visible in 11c
where the patient is suffering from testicular atrophy. 
This specimen demonstrates a large number of discrete high 
molecular weight proteins (80-200 kDal) which are not 
generally observed in seminal plasma, while the low
molecular weight components are somewhat reduced.
4• Other Pa t i ents wi th Uni oue Semina1 PIasma
Character!sties Specimen RS0 3 4 (Figure 12a) was produced
by a patient eshibiting severe oIigozoospermia as well as 
hyperspermia. He had also suffered from epididymitis three 
months prior to the collection of this specimen. As seen in 
the severely oligozoospermic varicocele patients discussed 
previously, the series VII proteins are present in
increased amounts. There is very faint evidence of the 
presence of series I proteins There are sia distinct hTf 
spots as opposed to a normal heterogeneous band. There is 
also considerable vertical streaking between the acid
phosphatase isomers and the series VII proteins which is
only observed in a few other specimens.
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Patient RS014 (Figure 12b) is a 23 year old diabetic. 
His diabetic classification and level of control are 
unknown. He was hypospermic (semen volume 0.7 ml) as well 
as asthenozoospermic (total mobility 11%). The sperm count 
was within the normal range, but approximately one third of 
the sperm were dead. The most striking observation in this 
e 1ectropherogram is the heterogeneity and increased levels
of albumin due possibly to non-enzymatic glycosylation. 
This gel also shows signs of incomplete liquefaction as 
shown by the presence of faint bands of protein in the CP5-8 
regions. Two prominent proteins are also observed in the V 
or L series area. These have been designated Va and V b .
Several individuals presented with polyzoospermia - or 
sperm counts greater than 250 million/ml. RS006 had 
undergone a varicocelectomy 4 months prior to this analysis. 
His count was over 400 million/ml (total count = 1.2
billion!) with about 3 0% of these being dead. Motility was 
about 50%. Series VII proteins were enhanced as well as
those in area C. Series I proteins are visible. Other
areas appear to be normal.
RS031 had a count of 225 million/ml with about 12% dead 
and 75% motility. The electropherogram shows some very
obvious differences from normal. When compared with Figure
7, however, one can see proteins similar to those found in 
pre-ejacu1 atory fluid superimposed on an otherwise typical 
HSP protein distribution. Re-analysis of this same specimen 
one week later gave rise to a relatively normal protein 
distribution (see Appendix D-31).
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HSP 2414 was produced by an individual whose wife was 
undergoing evaluation for admission to the EVMS Vital 
Inception of Pregnancy (VIP) Program. This individual was a 
34 year old white male who had undergone varicocelectomy in
November of 1982 (eight months prior). He and his wife had
been attempting to conceive for almost two years. Hormone 
analysis revealed slightly increased testosterone levels 
<1200 ng/ml) and decreased levels of FSH (11 mlU/ml). Trace 
metal analysis revealed low levels of zinc (45000 ug/L). In 
observing Figure 12e, one can see three repeating patterns 
of spots in the vicinity of albumin differing in molecular 
weight by about 5-6 kDal. Acid phosphatase (FI) is 
completely lacking from the pattern: the small series of
spots in this region represents a series of proteins which 
migrate just ahead of ACP and which are observed in most 
normal specimens. Decreased or absent ACP levels correlate 
well with the low zinc levels observed in this specimen 
since acid phosphatase is a zinc-containing enzyme. Other 
prostatic secretions are present in this specimen however,
as indicated by the presence of P2-P4 proteins. Series A
proteins are also present, but in reduced amounts.
Appendix D gives a complete listing of HR2DE gel 
tracings from most of the patients and donors evaluated in 
this project. These data are offered so that a
retrospective analysis of specimens can be made as new 
information from future seminal plasma studies becomes 
available.
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V. DISCUSSION
Initial time course studies were oriented towards 
determining a consistent time to sample the seminal plasma 
after ejaculation. Optimally, it would be desirable to 
sample the specimen as soon after collection as possible. 
However, it was generally not feasible to have the patient 
collect the specimen at the laboratory (especially at the 
Leigh office or for the Lamaze volunteers) because of the 
lack of privacy and psychological factors associated with 
masturbation in "public". These psychological factors can 
lead to inhibition of arousal resulting in difficulty in 
producing a specimen, or the production of a poor quality 
specimen (as compared with semen emitted under the influence 
of high levels of neuro- and hormonal stimulation associated 
with actual intercourse).
An alternative would be to provide the patient with a 
collection container containing a preservative solution of 
some sort to prevent any changes from taking place prior to 
analysis (analogous to adding heparin or EDTA to whole blood 
to prevent clot formation). However, since these specimens 
were usually collected under the direction of a physician to 
obtain the diagnostic information normally associated with a 
"routine" semen analysis, this was not possible either. 
Therefore, since (as previously discussed) few changes could
67
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be observed in the electropherograms after about 90 minutes, 
it was decided that this would make a good "standard" 
denaturation time for the patient studies at least. This 
provided ample time for the patient to deliver the specimen 
to the laboratory and to do the initial work-up necessary 
(see Apendix C) on the specimen prior to denaturation. Use 
of this 90 minute timespan as a standard for denaturation 
depends on the patient's honesty in accurately reporting the 
time of collection.
After these initial studies, it was subsequently decided
that a closely controlled analysis of the initial events 
associated with liquefaction should be studied. Analysis of 
a non-1 iquefied specimen presented technical problems, 
however. Accurate pipetting of a "gel" was difficult and
was resolved in part by cutting the ends off of the plastic 
pipet tips so that the coagulum could pass through the 
resulting wider bore. In addititon, there was some concern
about the possibility of contamination of the seminal plasma 
with sperm proteins since it was not possible to remove 
them by centrifugation prior to denaturation. It has been 
shown by others (79) that considerable concentration of
sperm protein extracts is necessary before spermatozoal 
proteins can be visualized. Even then, it is necessary to 
use silver-staining techniques to observe any significant 
amounts of protein. As additional proof that spermatozoal 
contamination of HSP was not a problem in gels stained with 
Coomassie Brilliant Blue (CBB), liquefied seminal plasma
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from a donor was denatured both with and without
centrifugation to remove sperm and subsequently analyzed by
HR2DE with no observable differences found (results not
shown).
The observation that the coagulation proteins could be 
visualized as well as their subsequent diminution with time 
demonstrates that semen additives are not necessary to carry 
out this type of analysis. It does however, require
patient/donor cooperation in providing a specimen "on
demand" to the laboratory as soon as possible after
collection (within five minutes).
Continued use of the "standard" 90 minute denaturation 
time probably still represents a realistic approach for 
future routine analysis however: especially in specimens
where there is no reason to suspect that liquefaction is a
problem (i. e. the specimen has liquefied). Caution must be
given however, to differentiate between incomplete
liquefaction and seminal plasma with a high viscosity. Very 
viscous specimens are difficult to handle both for routine
semen analysis and for analysis by HR2DE. The few very
viscous specimens that were analyzed by this technique
either provided poor quality gels, or little in the way of
meaningful results. The technical problems associated with 
this classification of specimens still need to be addressed.
In its original conception, it was invisioned that the 
bulk of the useful information gathered in the course of 
this research would come from the evaluation of seminal 
plasma from different classes of individuals with previously
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diagnosed abnormalities thus allowing us to make comparisons 
between specimens based on known differences etc.. However, 
due to the rarity of certain disorders, the lack of patient 
availability, and, in some cases, patient cooperation, it 
was possible to obtain only a few specimens of this type 
providing any useful information. Considering the
availability of specimens from the Andrology Laboratory and 
a renowned local urology practice - both dealing with
fertility disorders and artificial inception of pregnancies 
etc., this seems to be a bit surprising. However, even with 
the large volume of research that has been accomplished over 
the years dealing with male fertility, "idiopathic 
o 1igozoospermia" is all too often still a common diagnosis. 
In other cases where a "diagnosis" is more certain, an 
explanation of "why" certain semen parameters are present is
often not possible.
The split ejaculate technique has often been considered 
a "crude" means of obtaining fractionated semen although the 
"partitioned" nature of semen has been known since the late 
eighteenth century (5, p. 56). Consideration had been given 
to using this technique early on in this study. However, it 
was not until the end of the project that funds were made 
available to provide remuneration for the services of a 
group of donors specifically solicited for this purpose.
The data collected in these split ejaculate studies 
provided a great deal of information about the protein 
contributions of the various accessory organs and their 
distribution on HR2DE separation. Comparison of these
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various fractions with e 1ectropherograms of whole semen then
allowed for a retrospective evaluation of the almost one
hundred patient specimens previously analyzed. It then
became possible to look at some of these results which had 
been classified as abnormal, artifactual, or, as in one case 
(RS031), thought to be due to contamination, and re-evaluate 
them in terms of specific accessory organ (d y s - )funetion.
Obtaining pure prostatic fluid from healthy individuals 
is a difficult task. Frostatic palpation on rectal
esamination is an uncomfortable procedure - not one that men 
usually submit to willingly (especially after the initial
experience!>. Healthy individuals do not normally produce
any significant quantity of fluid which is able to be
collected for analysis. As men age however, and prostatic
hypertrophy becomes more apparent, fluid is more likely to 
be expressed. The question is, however, does this represent 
a normal specimen?
Comparison of split ejaculate first fractions with 
prostatic fluid has allowed us to differentiate which 
components in a map of whole seminal plasma are contributed 
specifically by the prostrate (see Figure 8). Other studies 
have made use of prostatic fluid expressed from glands which 
had undergone the trauma of surgical removal or autopsy 
prior to analysis (see for example Dermer et al. C433). The 
split ejaculate technique, on the other hand, provides a
convenient method of analysis resulting in no patient 
discomfort, or introduction of artifacts by use of
pathological or surgica11y-removed material.
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Use of the split ejaculates in conjunction with HR2DE in 
this project has also given further evidence in support of 
the sequential release of accessory organ components during 
the ejaculatory process. In addition, there is some
evidence of the heterogeneity of the prostate gland itself 
in that different portions of the gland (as described by 
McNeal for example C19, 821) may be functioning in concert 
to produce a composite fluid consisting of the secretions of 
several functionally different glands. This would offer a 
basis of explanation for the seminal plasma results observed 
in specimen HSP 2414 shown in Figure 12. In this specimen, 
the acid phosphatase isomers are completely lacking while 
other prostatic components are present. If the gland were
functioning as a unified organ, it would seem that all of 
the components would be altered as a result of a given 
abnormality. In light of the fact that the gland is being 
influenced by both hormonal and neural stimuli, especially 
during arousal, it is highly probable that different 
anatomical areas would respond differently to both of these 
types of stimuli and that this would be reflected in the 
composition of the fluid as a whole as it is being released. 
Thus, one could explain why certain prostatic components 
decrease more rapidly in concentration than others when 
observed in serial split ejaculate fractions such as was 
shown in Figure 5, or how some components can be present in 
a specimen such as HSF 2414 and others not. Of course, the
absence of components in a specimen such as this might also
represent the observation of a genetic deficiency or a
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post- 1ransI ationa1 defect resulting in the absence or 
relocation of certain protein constituents.
The protein P3 in Figure 4 is tentatively identified as 
Iysozyme based on its similarities of physical 
characteristics and migrational properties with the low 
molecular weight standard marker protein Iysozyme. The 
presence of Iysozyme in high concentrations in prostatic 
fluid (as reported by Tauber [303) and the fact that there 
are only two major proteins observed to be migrating in the 
15,000 dalton molecular weight range of both first fractions 
and pure prostatic fluid make P3 a possible candidate - 
especially since P4 was previously identified by Carter and 
Resnic (53) as Prostatic Binding protein. The fact that no 
other protein spots are showing up in this low molecular 
weight region (or any other region) does not necessarily
mean that they are not present in the specimen however.
Proteins with isoelectric points below about 4, or above 7.5 
will either migrate off of the first dimension gel or not
enter it because of the limited pH gradient, and thus would 
not be visualized in the second dimension e 1ectropherogram. 
Additional confirmation of the location of Iysozyme is 
n e eded.
Both the time course studies and the split ejaculate
analysis have demonstrated a class of very basic proteins
dubbed "coagulation proteins" along the right-hand, or
basic, gel margin from ejaculates denatured very soon after 
collection of the specimen. That these series of proteins
rapidly disappear as semen liquefaction progresses
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implicates their involvement with the formation and 
dissolution of the seminal clot. Observation of these
proteins in terminal fractions of the ejaculate stream 
further indicates that they are produced by the seminal 
vesicles, which are known to be associated with semen 
coagulation. The enzymes responsible for semen liquefaction 
are assumed to be produced by the prostate. Identification 
of those components in first or prostatic fractions 
responsible for initiating this activity has not been made 
however.
As observed here and by others (73), the cleavage 
products of the liquefaction process do not appear to be 
present in the gel once liquefaction is completed. That is, 
there appears to be no quantitative increase in any given 
protein spot in the gel with time. Our initial assumptions 
were that some of the low molecular weight components (in 
the range of 10-15 kDal) might possibly represent some of 
these cleavage products, but these misconceptions were 
dispelled when we observed that most of these components
were present in whole semen almost immediatly after
ejaculation. The observation of a regular decrease in 
molecular weight of the successive coagulation proteins (CP 
1-8) would seem to indicate that small peptide fragments (5 
kDal or less) are being cleaved off of CP-1 and traveling
with the salt front in the second dimension gel. Often
times there is observed a non-specific staining of the lower 
right corner of the slab gel which may represent a
homogenious staining of these peptide products. \
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The existence of macroscopic seminal globules in some 
fresh semen specimens is commonly acknowledged, but they are 
generally not present in a majority of specimens observed. 
Their presence may possibly be associated with some 
pathological condition which affects semen liquefaction. 
The fact that these globules were shown to be “packets" of 
seminal vesicular secretions due to the similarity with 
terminal split ejaculate fractions would tend to confirm 
these observations. Little has been reported in the
literature about these globules other than their observed 
p resence.
Donors providing the scant urethral gland secretions,
or "pre-ejaculator fluid" (PEF) used in this study reported 
that these secretions were difficult to produce “on demand" 
using purely mechanical stimulation (i. e. masturbation). 
One individual found it necessary to elicit the assistance
of a female partner to provide the stimulus necessary for
production of this secretion. This would lead one to 
believe that their incidence of detection would be low in 
specimens collected by relatively unstimulated masturbation, 
due to their low volume of secretion (3-5% of the total 
ejaculate) and their low protein concentration. Indeed, 
visualization of the protein spots in Figure 7 was only 
accomplished by restaining the gel using a silver stain 
technique after initially staining it with CBB R-250. The 
initial CBB stain showed only very faint spots in the 
vicinity of series D and G whereas silver staining gave the 
results shown in Figure 7 (see also Appendix D-77B).
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Analysis of specimen RS031 revealed a constellation of spots 
superimposed on a normal HSF protein distribution. This 
superimposed pattern had a remarkable resemblance to the 
pattern in the analyzed PEF specimens. The circumstances 
surrounding the collection of this particular specimen are 
unknown, other than the fact that it was produced at home 
for a routine semen analysis by an individual who had an 
elevated sperm count (225 million/ml).
Re-analysis of the same specimen one week later showed
the disappearance of these proteins leading us to believe 
that the initial analysis was contaminated by some unknown 
source. Retrospective analysis almost six months later 
after carrying out the PEF studies showed that the source of 
this "contamination" might have been urethral gland 
secretions which subsequently disappeared with standing, or 
in association with freezing and thawing of the specimen for 
re-ana lysis.
Mucous membranes guarding the entrances to the body are
rich in immunoglobulin A (IgA); a secretory dimer of IgA
slightly different in composition from circulating serum IgA 
in the bloodstream. This component maintains vigilance at 
these body orifices providing immunological defense against 
the invasion of potentially harmful substances. Secretory 
IgA consists of two IgA monomers which are complexed with 
what has been described by Tomasi and Bienenstock (80) as a
secretory component (SC) protein, and a "J-Fiece" protein
described by Koshland (81). SC was reported to have a
molecular weight of 58000 Daltons, while the "J-piece" is a
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negatively charged protein with a molecular weight of 15000 
Daltons (as determined by gel filtration). There are
several proteins in the pre-ejacu1 atory fluid represented in 
Figure 7 that may correspond to these secretory components. 
Proteins in Series E and F have similar migrational
characteristics to the light and heavy chains of IgA 
respectively. Protein G is a very prominent spot with a
molecular weight ranging from 59-65 fcDal. Proteins in area 
H are acidic (pi 4.5-5) and have a molecular weight of 30000 
Da 11 o n s .
Detection of IgA in secretions from the mucosa of the 
distal or cavernous urethra is in accordance with findings 
in other mucosal membranes. The findings of Tauber et al. 
in 1974 (28) showed that IgA could be immunoIogicaI Iy 
detected in initial portions of the split ejaculate, with 
decreasing concentrations in subsequent fractions. IgA was 
not detected in 15% of their specimens, however. This may
be due to the level of stimulation at the time of
c o 11ec t i o n .
Another interesting observation in PEF is the increased 
presence of the high molecular weight series VII proteins 
noted previously. This series of proteins was also observed 
to be increased in many of the o 1igo zoospermic patients 
(sperm count of less than 50 mi 11ion.m l ) we observed, and in 
even greater amounts in most of the severely o 1igozoospermic 
patients (count less than 5 million/ml). The significance 
of this observation is not known.
In their paper on the e 1ecrophoresis of seminal plasma
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(73), Edwards et al. described a group of proteins ("Group 
A") that were observed to be present in "fertile" 
individuals, but not in post vasectomy patients. They 
proposed that these proteins may be of testicular origin. 
These observations were based on a comparison of three 
post-vasectomy patients with five "normal" specimens. We 
have observed a group of proteins (designated Series I) 
which have similar migrational characteristics (relative to 
P2> to D e w a r d s ' Group A. Observation of over 200 seminal 
plasma e 1ectropherograms has shown that our series I is not 
always present in "intact" individuals, and does appear to 
be present in at least one post- vasectomy seminal plasma 
evaluated (RS053). The length of time after the vasectomies 
was not given by Edwards (73). Most of our post-vasectomy 
patients were submitting their semen for a post-operative 
verification of the absence of sperm. Detection of these 
proteins in recent vasectomy specimens may represent 
residual secretions since it is known that sperm may be 
present up to several months after vasoligation. On the 
other hand, absence of this protein in long term vasectomy 
patients may represent the loss some accessory gland 
secretion that was closely associated with testes-specific 
factors.
The absence of this series in "intact" patients can 
also be associated with subfertility or some pathological 
condition such as varicoceles. The absence of this group of 
proteins in most oligozoospermic varicocele patients 
evaluated may indicate that it is associated with testicular
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function. Its observed presence in two only slightly
o 1igozoospermic patients <RS018 and RS030) may indicate that 
the particular lesion produced may only be associated with 
prolonged venous incompetence, and that early surgical 
intervention might prevent the disappearance of this
substance. This is an area that demands further study.
A final comment is added to discuss the absence or 
presence of proteins observed in seminal plasma. All of the 
proteins observed in seminal plasma electropherograms are
not necessarily specific to the male reproductive system. 
Some of these proteins may represent transudates from serum 
(73) or may be present as a result of infectious processes. 
The presence of significant levels of pathogenic organisms 
as well as the body's immune response to these organisms may 
contribute observable levels of protein to the seminal 
plasma e 1ectropherogram. One of our prospective donors with 
a history of trichomoniasis was observed to have a high 
level of unidentified organisms in his semen.
E 1 ectropherograms of his seminal plasma (Appendia D-63) 
showed a general increase in the numbers of proteins 
observed throughout the gel. Additional work in this area
may prove to be fruitful.
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VI . SUMMARY
In this work, we found that it is not necessary to add 
proteolytic inhibitors to seminal plasma in order to observe 
proteins associated with liquefaction if the specimen is 
analyzed immediatly after collection. For studies of 
proteins other than those associated with
coagulation/1iquefaction, we found that 90 minutes
represents a good "standard" denaturation time with few 
observable changes in the HSF e 1ectropherograms after this 
t ime .
The split ejaculate technique provides a very good 
means for studying accessory organ secretions, and for the 
identification of protein constituents associated with these 
glands. As the ejaculation sequence progresses, one can
observe definite quantitative changes of various protein
components associated with both the prostate and the seminal 
vesicles.
Our prostatic fluid e 1ectropherograms are almost 
identical to the distribution of proteins in initial split 
ejaculate fractions, and compare favorably with the work of 
Dermer et al. (43) and Carter and Resnick (48). We suggest 
that additional work be carried out to see if protein F3 
represents Lysozyme.
Analysis of macroscopic globules found in whole semen
80
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has shown that these substances represent "packets" of
unliquefied seminal vesicle secretions. The distribution of 
proteins in e 1ectropherograms of these secretions match
those found in terminal fractions of split ejaculates.
Pre-ejacula tory fluid has been analyzed for the first 
time by HR2DE, and shows a distribution of proteins
characteristic of acidic sia 1omucoproteins. Ve suggest that 
confirmation of the presence of secretory IgA in these
secretions be made by co-electrophoresis of slgA and by 
immunological methods.
Several series of proteins appear to be associated with 
male fertility status. Series 1 proteins may, or may not, 
be identical to the Group A proteins of Edwards (73). These 
proteins were observed to generally be absent in 
post-vasectomy patients , and in severely ol igozoospermic 
patients, but were observed in at least one post-vasectomy 
patient, contrary to Edwards' results. Series VII proteins 
are also associated with severe oIigozoospermia. The
significance of these results are not known. It is
suggested that additional studies be carried out in these 
areas.
In closing, the almost constant association with this 
project for the past five years has provided the opportunity 
to spend many sometimes exciting moments and often-times 
arduous hours immersed in the basic research of human male 
fertility. The chosen technique - High Resolution
Two-Dimensional Electrophoresis - was a relatively new
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technique when we first began to use it in 1978. It has 
since come into great popularity as a very powerful
analytical tool for the analysis of complex biological
specimens. We have shown that it is particularly well
suited for the analysis of human seminal plasma, and, when 
coupled with the split ejaculate technique, provides a very
simple means for determining which components of whole
seminal plasma are contributed by the various accessory sex 
organs associated with male reproduction.
Application of these results to patient data has
provided, and should continue to provide, additional insight 
into some of the possible reasons for reduced male
fertility. As a result, it is hoped that ultimately some 
form of medical treatment may be provided so that these 
individuals may go forth and
"...be fruitful and mu 11 i p 1y . . ."
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APPENDIX A-1
Locally Fabricated Vertical Slab Gel Electrophoresis
Chamber
(see Figure Al)
a. Upper Buffer Chamber: 145 h 70 a 50 mm.
b. Faceplate: 1/2“ white Plexiglass cut 215 x 175
mm (notch 135 x 40 mm).
c. Faceplate Gasket: 5/16" OD x 3/16" ID x 1/16"
wall Tygon tubing.
d. Notched plate: 1/8" DSB glass plate cut to
pattern 190 x 165 mm (notch 20 x 135 mm).
e. Spacer: 190 x 10 x 1.5 mm Teflon.
f. Sealing Gasket: 3/32" OD x 1/32" ID x 1/32" wall
Tygon tubing.
g. Front Plate: 1/4" plate cut 190 x 165 mm.
h. Clamp: Cut from 1/2 inch aluminum
i. Lower Buffer Chamber: 190 x 190 x 55 mm.
j. Platinum Wire: 26 gauge x 150 mm.
All Plexiglass except the Faceplate is cut from 
1/4" stock and milled to size. Pieces were 
glued together with Plexiglass Solvent.
Chambers were sealed with silicone caulk to 
prevent leakage.
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FIGURE A - 1 Vertical Slab Gel Electrophoresis
Chamber
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APPENDIX A2
Acrylamide Gradient Casting Apparatus
A
A. Gradient Miser (Pharmacia GM-l)
B. Manifold: Constructed from a piece of 1/2" OD, 1/4" 
ID plexiglass tubing capped at both ends with holes 
drilled to accept nine tubing nipples (Technicon 
part number 116-0061F02) which were sealed in place 
with epoxy cement.
C. Technicon Auto-Analyser Proportioning Pump
D. Pump Tubing: (Technicon part number 116-0532P14)
color coded Green-Green; flow rate 1.0 m l /sin.
E. Upper Chamber portion of the Vertical Slab Gel
Electrophoresis Chamber with assembled glass plates.
Approximate Gel Volume: 30 ml/gel (total volume ■ 250 
ml )
Casting Time: Approximately 15 minutes.
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APPENDIX B 
Solicitation of Human Subjects 
The following forms were submitted to, and approved by, 
the Old Dominion University Institutional Review Board for 
the Protection of Human Subjects for use in soliciting semen 
donors for this project.
Individuals with recently proven fertility were sought
from area Lamaze/Parenthood training classes with seven
individuals responding. Semen donors for the specialized 
collection projects were solicited from the Andrology
Laboratory donor pool and through limited on-campus (both 
ODU and EVMS) advertising.
The Solicitation Form (Appendix B 1 > was handed out by 
Lamaze instructors as a first approach to those individuals. 
On a subsequent class meeting, the primary investigator for 
this project met with interested individuals and presented a
brief over-view of the project's goals (Appendix B 2 ). Those
choosing to participate filled out the Informed Consent Form 
(Appendix B 3 ) and the Questionaire (Appendix B 4 ). They were 
given a copy of the Collection Instructions (Appendix B 5 ) 
along with a container and asked to complete the Collection 
Data form (Appendix B6) at the time of collection.
Similar instructions were given to the other donors 
except that the Solicitation Form was not used and 
collection instructions were as given in para. D.l.b and c.
B1




Several area scientists are investigating some of the causes 
of male infertility in conjunction with the ODU Andrology 
Laboratory, the ODU Clinical Chemistry Program, and the 
Biomedical Sciences Program at Eastern Virginia Medical 
School. In support of these research projects, volunteers 
are needed with recently proven fertility to donate semen 
specimens to be used solely for biochemical, immunological, 
and trace metal analysis (absolutely NO specimens will be 
used for any type of insemination experiments). All data 
will be held strictly confidential. If you would be 
interested in participating in these projects, please notify 
your instructor during the break or after class. There will 
be a short meeting with some of the scientists involved 
during the break at next week's class to give out additional 
i nfo rma t i o n .
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APPENDIX B 
Solicitation of Human Subjects 
The following forms were submitted to, and approved by,
the Old Dominion University Institutional Review Board for
the Protection of Human Subjects for use in soliciting semen
donors for this project.
Individuals with recently proven fertility were sought
from area Lamaze/Parenthood training classes with seven
individuals responding. Semen donors for the specialized 
collection projects were solicited from the Andrology
Laboratory donor pool and through limited on— campus (both 
ODU and E V M S > advertising.
The Solicitation Form (Appendix B1 ) was handed out by 
Lamaze instructors as a first approach to those individuals. 
On a subsequent class meeting, the primary investigator for 
this project met with interested individuals and presented a
brief over-view of the project's goals (Appendix B 2 ). Those
choosing to participate filled out the Informed Consent Form 
(Appendix B 3 ) and the Questionaire (Appendix B 4 ). They were 
given a copy of the Collection Instructions (Appendix B5) 
along with a container and asked to complete the Collection 
Data form (Appendix B6) at the time of collection.
Similar instructions were given to the other donors 
except that the Solicitation Form was not used and 
collection instructions were as given in para. D.l.b and c.
B 1
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fertilty status. We have developed a technique (High 
Resolution Two-Dimensional Electrophoresis) that enables us 
to simultaneously evaluate several hundred protein
constituents in a given semen specimen. We believe that 
these complex protein patterns are related to an
individual's fertility status, and have used this technique 
to evaluate the seminal plasma of a number of infertile 
patients. It is necessary at this point however, to compare 
these results with specimens contributed by individuals who 
have recently proven that they are fertile.
Trace metal analysis of semen is another area of
investigation that may provide the physician with
information aiding in his diagnosis and possible treatment 
of infertility problems. Certain trace elements (or m in­
erals) such as iron, copper, zinc, and selenium are 
essential for proper protein function and metabolism.
Conversely, elements such as cadmium or lead are associated 
with toxic exposures and can seriously affect fertility. We 
have looked at these metals and others in seminal plasma
from infertile males and it is now necessary to again,
compare these results with data from proven fertile
ind i v iduaIs .
Masturbation is the method of choice for collection of 
semen for the above analysis. Other collection procedures
are not acceptable because they may lead to contamination of 
the specimen from various outside sources. There are no 
known medical risks associated with semen collection via 
this method. The benefits that may be derived from
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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APPENDIX B3 
Informed Consent Form 
Project Name: Human Semen Evaluation
This is to certify that I, ________________________________  ,
hereby agree to participate as a volunteer in a scientific 
investigation as a part of the educational and research 
program of Old Dominion University under the supervision of
Drs. James H. Yuan, Patricia A. Pleban and Edward E. Gaunt.
The investigation and the nature of my participation 
have been described and explained to me, and I understand 
the explanation. I further understand that I may withdraw 
from the project at any time, without penalty or prejudice.
I have been afforded the opportunity to ask questions 
concerning the purpose of this project and all such
questions have been answered to my satisfaction. I
understand that should I have additional questions in the
future about this project or the manner in which it is
conducted, I may contact one of the above named individuals
at 440-4078.
I understand that I am free to withhold any answer to 
specific items or questions in any questionnaire submitted 
to me for this project. I understand that any data or
answers to questions will remain confidential with regard to 
my identity. I further understand that no data will be
identified with me nor will any information be released to
persons outside of the research team without the team first
obtaining my written permission.
I acknowledge that I was informed that there are no 
known risks which can be incurred as a result of
participating in this experiment. Therefore, I understand
that no medical or psychological assistance will be made
available to me by either Old Dominion University or any
member of the research team as a result of any physical or 
emotional harm I may experience as a result of participating 
in this project.
I have been informed that I have the right to contact 
the Old Dominion University Institutional Review Board for 
the Protection of Human Subjects should I wish to express 
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APPENDIX B4 
D O N O R  I N F O R M A T I O N
Specimen #
Age Area of Residence
Weight Occupation
Height Race
1. How many children have you conceived?
2. Have you had any major illnesses in the last six months 
(i.e. flu, bad colds, fever, allergies)?
3. Are you taking any drugs or medications (please list)?
4. Do you take vitamins? If so, what kind?
How often do you take them?
5. Have you ever had any type of reproductive organ 
problems such as prostatitis, epididymitis, tortion, 
varicocele, etc? If so, how was this treated?
6. Have you ever had the mumps? Venereal Disease?
7. Have you ever had any types of rheumatoid diseases 
(arthritis, etc)?
8. Do you now smoke, or have you smoked in the past year? 
How much, on an average, per day?  packs/day
9. Are you exposed to any type of toxic substances on your 
job such as metal fumes (from welding, etc.), solvent 
vapors, radiation, etc.? Please describe.
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APPENDIX B5
C O L L E C T I O N I N S T R U C T I O N S
Realizing that semen collection by masturbation is a 
"touchy" subject for most men, we would like to make this as 
easy for you as possible. You have been provided with a 
specimen container in which the semen is to be collected and 
transported, and some information sheets to be filled out. 
Please fill them out as completely as possible. All
information will be held in strictest confidence.
In order for you to provide a specimen that is
scientifically useful, it is necessary that you follow 
certain collection procedures. An abstinence period of 
between three and five days is required in which no
ejaculations occur. If a specimen is collected less than 72 
hours from a previous emission, the semen may not have had 
enough time to be replenished with sperm and other semen
components resulting in a biased analysis. Similar problems 
occur if it has been longer than five days since your last 
emission. Additionally, it is absolutely necessary that the 
entire ejaculate be caught in the collection container. If 
any of the specimen is lost it will seriously affect the 
results. To avoid contamination, please do not remove the 
blue cap from the collection container until just prior to 
collection. Ensure that your hands and genital areas are
clean, and that no pubic hairs fall into the container.
Once you have successfully collected the specimen,
accurately note the time it was collected and other 
information requested on the reverse side of this form. Time 
o f c o 11ec t i on is impo r t a n t . It is necessary that the sample 
be delivered to the lab within ONE HOUR of this time. Also, 
please do not subject the specimen to heat or co ld--idea11y 
it should be kept at body temperature until delivered.
Thank you for your cooperation. If you have any 
questions please call 440-4104.
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C O L L E C T I O N  D A T A
Specimen #__________ Date
Time Collected:__________________
(Please deliver to the lab 
within ONE HOUR of this time)
Was any specimen lost during collection?
Date of last intercourse or ejaculation:
THANK YOU FOR YOUR COOPERATION
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APPENDIX C 
SEMEN ANALYSIS PROCEDURES 
The following procedures are used to evaluate semen 
received from patients or donors.
Rece i o t o f Spec imen
1. Upon receipt of the specimen, ensure that the time of
collection is accurately noted. Obtain this information 
from the patient along with all other information not
recorded.
2. Note state of liquifaction and specimen color (yellowish 
color may indicate a high count).
3. Measure the semen volume (after complete liquifaction)
with a wide bore 10 mL graduated serological pipet. (If
specimen is to be cultured, use a sterile pipet.)
4. ApproKimate1y 90 minutes after the noted collection
time, remove S00 uL of well mixed specimen using a metal
free pipet tip and centrifuge at low speed (less than 300 x
g) for five minutes in an acid washed 1.5 mL microcentrifuge
tube. Afer centrifugation, remove 100 uL of the seminal
plasma for denaturation and the remainder of the seminal 
plasma for trace metal analysis.
Mo t i 1 i tv Procedures
1. Prewarm glass microscope slides and eosin stain (0.5%
Cl
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w/v in distilled water) to 3 7 C.
2. Dispense SO uL of well mixed semen onto a prewarmed
labeled slide being careful not to form bubbles on the 
surface of the pool. Cover with a 24x40 mm coverslip and 
allow to settle for 5-10 minutes on the slide warming tray.
3. On another prewarmed slide dispense 50 uL of semen and
15 uL of warmed eosin stain Mix well with the pipet tip
and coverslip. Allow the slide to settle while doing the
mo t i1i ty c o u n t .
4. Count a minimum of ten microscope fields for each
classification of motility (i.e. quick progressive, 
sluggish, and non-motile) using the oil immersion objective.
5. To determine the live/dead ratio, count a minimum of ten 
fields on the eosin stained slide, differentiating between 
live non-motile sperm (non-staining) and dead sperm (pink 
colored) using the oil immersion objective. %dead = (# pink 
staining sperm) / (total non-motile sperm) x 100.
Moroholoav Procedures
While doing the motility counts, one should be on the 
look-out for abnormal sperm types. A table of commonly 
encountered sperm types is given by Zaneveld and Polakoski 
in (29). The particular type of abnormality observed along 
with its prevalence should be recorded.
Sperm Co un t i no Procedures
1. Based on sperm populations observed during motility
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studies, make up two of the following dilutions (i.e. if
there are a large number of sperm in a high power field make 
up a greater dilution than if only a few are observed.).
1:25 Dilution (Dilution Factor = 25)
Pipet 2.40 mL of Sperm Diluting Solution (0.37% v/v
formalin in 0.6 mo 1/L bicarbonate buffer) into a clean 
10 mL vial and add lOOuL of well mised semen. Cover the 
vial and invert several times to mix.
1:50 Dilution (Dilution Factor = 50)
Pipet 4.90 mL of Sperm Diluting Solution into a 10 mL
vial and add 100 uL of well mixed semen. Cover the tube 
and invert several times to mix.
1:75 Dilution (Dilution Factor = 74.96)
Pipet 5.00 mL of Sperm Diluting Solution into a lOmL
vial and add 66.7 uL of well mixed semen. Cover the
vial and invert several times to mix.
1:101 Dilution (Dilution Factor = 101)
Pipet 5.00 mL of Sperm Diluting Solution into a 10 mL
vial and add 50 uL of well mixed semen. Cover the vial
and invert several times to mix.
2. Allow dilutions to set for 10-15 minutes to ensure
complete sperm kill.
3. Apply the specimen to a dry hemocytometer and allow
sperm to settle to the counting plane in a humidified Petrie 
dish for 5-10 minutes.
4. Count the number of whole sperm/sperm heads in each of
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the four corner grids (El, E 2 , E3 , and E4 in the diagram) 
and the center grid (E5>. Include those sperm touching the 
left and lower boundaries of the grid but not the right or 







5. If sperm concentration is less than 20 million/mL the
count must be made using the four outer corner grids (marked 
A-D above) as well as the entire center grid (marked E ) .
5. Count the second dilution as above and calculate the
results as follows:
Multiplication Factor (MF) =
2000 (Grids A, B, C, D, and E)
50000 (Small grids El, E 2 , E 3 , E 4 , and E 5 )
SPERM CONCENTRATION = MF X Dilution Factor (D F ) X # counted
TOTAL SPERM COUNT = Sperm Concentration X Semen Volume
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7. Comparison of the counts resulting from the 
different dilutions should agree within +. 10 %:
f (Count A - Count B)7 X 100 = % Error
L Count A J
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APPENDIX D
The date in the following appendix represent a 5 0%
reduction of actual gel tracings. These tracings were
produced by placing the gel on a "light box" to provide
fluorescent backlighting and then tracing the observed
pattern of spots in the gel onto a 8"X 8"X 1/16" glass plate 
placed on top of the gel. Tracings were accomplished by 
using a fine tip permanent ink marker. The tracings were 
then transferred to a piece of paper in a similar manner.
The information in these tracings is a two-dimensional 
representation of three-dimensional information. That is,
one should not assume any quantitaive information from the 
size of the spot: size in no way represents staining density
and thus protein concentration in the original gel. These
tracings are provided to convey protein positional
information only.
D-l
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The molecular weight marker proteins were generally 
added to most second dimension separations. These proteins 
can usually be observed along either the right or left hand 
margin of the gel. The proteins used and their approximate 
molecular weights are given as follows:
Myosin .................... 200000
(J-Ga 1 ac t os i da se . . . . . 116 3 0 0
Fhosphory1ase B 92500
Bovine Serum Albumin 670 00
Ovalbumin ............... 45000
Carbonic Anhydrase 31000
Soy Trypsin Inhibitor 21500
Lysozyme .................. 14400
The pH gradient along the bottom of the gel ranged from 
4-4.5 along the left margin to 7.5-8 along the right margin.
Figure 8 is included again in this appendix for easy 
re ference.
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Mr. Edward ElIwood Gaunt was born October 28, 1949, in
Woodbury, New Jersey to parents C. Richard Moorehouse Gaunt 
and Janet Horner Gaunt. He married the former Miss Carol
Marie Jones of Blackstone, Virginia in August of 1972. He 
has two children; Kevin Edward, and Ryan Matthew.
Mr. Gaunt graduated from Virginia Polytechnic Institute 
and State University with a Bachelor of Sciences degree in 
Biochemistry and Nutrition in June, 1972. He received his 
Master of Sciences degree in Clinical Chemistry from Old 
Dominion University in August of 1980.
After graduation in 1972, Mr. Gaunt was commissioned as 
an Officer in the United States Army and served two tours at 
the U.S. Army Field Artillery School at Fort Sill, OK, and 
four years in the Federal Republic of Germany where he was 
assigned to a LANCE Missile Battalion <lBn/333FA>. While in 
the Army, he received the National Defense Medal and two 
Army Commendation Medals. In addition, he was inducted into 
the Honorary Order of Saint Barbara.
While at Old Dominion University, Mr. Gaunt held 
several Graduate Teaching Assistantships, an ODU Research 
Foundation Assistanceship, and the University Doctoral 
Fellowsh i p .
Mr. Gaunt began study in the joint Old Dominion 
University and Eastern Virginia Medical School Biomedical
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Sciences Program in July, 1980, where he received the 
Biomedical Sciences Program Fellowship for two terms. Mr. 
Gaunt will be the first Doctoral Candidate to graduate from 
the Biomedical Sciences Program.
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